AU3185300A - Chimeric promoters based on the plastocyanin pete promoter from pea - Google Patents

Chimeric promoters based on the plastocyanin pete promoter from pea

Info

Publication number
AU3185300A
AU3185300A AU31853/00A AU3185300A AU3185300A AU 3185300 A AU3185300 A AU 3185300A AU 31853/00 A AU31853/00 A AU 31853/00A AU 3185300 A AU3185300 A AU 3185300A AU 3185300 A AU3185300 A AU 3185300A
Authority
AU
Australia
Prior art keywords
seq
promoter
nucleic acid
acid sequence
chimeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU31853/00A
Other versions
AU767285B2 (en
Inventor
Veronique Gruber
Iann Rance
Manfred Theisen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meristem Therapeutics SA
Original Assignee
Meristem Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meristem Therapeutics SA filed Critical Meristem Therapeutics SA
Publication of AU3185300A publication Critical patent/AU3185300A/en
Application granted granted Critical
Publication of AU767285B2 publication Critical patent/AU767285B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Description

WO 00/56906 PCT/IB00/00317 CHIMERIC PROMOTERS BASED ON THE PLASTOCYANIN PETE PROMOTER FROM PEA 5 [DESCRIPTION] The present invention relates to chimeric expression promoters, particularly suitable and adapted for use in the field of plant biotechnology. In general, expression promoters are well known in the field of 10 biotechnology and genetic manipulation. Insofar as plant biotechnology is more particularly concerned, the degree of expression of a gene coding for a polypeptide that it is desired to produce in a host cell is often dependent on the promoter used. The various promoters that are ubiquitously used are often 15 limited to specific applications or particular cell tissues, simply because of their tissue specificity or expression strength. For example, one might cite the 35S promoter of the cauliflower mosaic virus as being a relatively strong promoter, compared to, say, the promoter originating from the nos gene, 20 both of these promoters being more particularly used in the field of plant biotechnology. There thus exists at the present time a need for new and useful promoters that enable one to overcome the problems inherent in the promoters currently used up until now. 25 One attempt to solve this problem has been reported in the PCT application published under the number WO 97/20056, which describes increasing the degree of genetic expression through the use of "enhancers", (i.e. having a positive effect on the activity of the promoter), in known promoters. The "enhancing" 30 nucleotide sequences are rich in A and T bases, the total amount of said bases coomprising more than 50% of the nucleotide sequence of the "enhancer". In particular, the applicants of this PCT application specify the use of an "enhancer" zone originating from the pea plastocyanin promoter. 35 The expressions used herein and in the claims are intended to have the following meanings : WO 00/56906 PCT/IBOO/00317 - "nucleic acid" means DNA or RNA ; - "nucleic acid sequence" means a single or double-stranded oligomer or polymer, of nucleotide bases read from the 5' extremity towards the 3' extremity, and includes 5 self-replicating plasmids, genes, polymers of DNA or RNA, whether infectious or not, and also DNA or RNA whether functional or not. In the nucleotide notation used in the present application, and unless otherwise mentioned, the left extremity of a single stranded nucleotide sequence is the 5' 10 extremity ; - "derived nucleic acid sequence" means that the sequence derives directly or indirectly from the sequence to which reference is made, for example by substitution, deletion, addition, mutation, fragmentation, and/or synthesis of one or 15 more nucleotides ; - "promoter" or "promoting nucleic acid sequence" means a region of nucleic acid upstream of a start codon for translation and which is implicated in the recognition and binding of polymerase RNA and other proteins involved in transcription ; 20 - "plant promoter" means a promoter that is capable of initiating transcription plant cells ; - "constitutive promoter" means a promoter capable of expressing nucleic acid sequences operably linked to said promoter, in all or nearly all the tissues of the host organism throughout the 25 development of said organism ; - "tissue specific promoter" means a promoter capable of epxressing, in a selective manner, nucleic acid sequences operably linked to said promoter, in certain specific tissues of the host organism ; 30 "operably or functionally linked" means the linking of the promoter or the promoter nucleic acid sequence, to a nucleic acid sequence, or gene, to be expressed coding for a protein which it is desired to produce, in such a way that the promoter positively inflences or drives transcription of the 35 linked nucleic acid sequence. It must be understood that that the promoter sequence may also include sequences which are 2 WO00/56906 PCTIBOO/00317 transcribed situated between the transcription start site and the translation start codon ; - "nucleic acid sequence, or gene, to be expressed coding for a 5 polypeptide that it is desired to produce" means a gene or nucleic acid sequence coding for a polypeptide, and preferably and exogenous or heterologous polypeptide, said exogenous polypeptide being more preferably a pharmaceutically, therapeutically or cosmetically active substance, such as a 10 protein, enzyme, inhibitor, receptor, antibody, antigen, therapeutically active fragments thereof. Exemplary heterologous or exogenous therapeutically active substances that may be produced through expression of corresponding genes or nucleic acid sequences in a host cell are structural proteins, such as 15 collagen, iron transfer proteins or transferrins, such as lactoferrin, blood derived proteins, such as hemoglobin, human serum albumin, erythropoietin, growth stimulating factors, proteolytic or anti-proteolytic enzymes, such as alpha-antitrypsine, hormones, secondary metoblites, digestive 20 enzymes, such as gastric lipase, pancreatic lipase, trypsine, chymotrypsine, alcohol dehydrogenase, brain derived neurotrophic factors,cardiac stimulators or modifiers, and blood pressure control agents such as angiotensins; - "expression cassette" means nucleotide sequences capable of 25 driving expression of a nucleic acid sequence, or of a gene, coding for a polypeptide which it is desired to produce in a host organism which is compatible with such expression cassette sequences. Such expression cassettes generally comprise at least one promoter and a transcription termination signal, and 30 optionally other factors necessary or useful for expression ; - "vector" means expression systems, for example projectiles coated with DNA, nucleic acid based transport vehicles, nucleic acid molecules adapted for delivering nucleic acid sequences, and circular self-replicating autonomous DNA, for example 35 plasmids, cosmids, phagemids, etc. If a recombinant micro-organism or recombinant cell culture is described as a 3 WO00/56906 PCT/IB00/00317 host for an "expression vector", this also includes circular extrachromosomal DNA (such as for example, mitochondrial or chloroplast DNA), DNA having been integrated into the host chromosome(s), the vector being either stably replicated 5 by the cells during mitosis as an autonomous structure integrated into the host genome, or maintained in the nucleus or the cytoplasm of the host ; - "plasmid" means a molecule of circular autonomous DNA capable of replication in a cell, and includes both "expression 10 plasmids" and "non-expression plasmids". If a recombinant micro-organism or cell culture is described as a host for an "expression plasmid", this also includes molecules of circular extrachromosal DNA and DNA having been integrated into the host chromosome(s). If the plasmid is maintained by a host cell, the 15 plamsid is either stably replicated by the cells during mitosis as an autonomous structure, or integrated into the host genome ; - "heterologous sequence" or "heterologous nucleic acid sequence" means a sequence orginating from a source or species that is foreign to the environment, or if it originates from the 20 same environment, has been modified with respect to its original form. The modification of the nucleic acid sequencecan occur for example through treatment of the nucleic acid with a restriction enzyme to generate a fragment of nucleic acid capable of beign operably linked to a promoter. The modificaiton can also occur 25 through the use of techniques like site specific mutagenesis ; - "box" means a nucleic acid sequence to which a regulatory function is attributed ; - "like" means that the box and/or nucleic acid sequence with which this latter term is associated, comprises a certain 30 sequence identity or homology with a known box and/or a known nucleic acid sequence indicated as a reference, and preferably a sequence identity of at least 50%, even more preferably a sequence identity of at least 75%, and most preferably a sequence identity of at least 90% with the reference sequence. 35 The percentage of identity of the sequence is calculated on the basis of a comparison window of at least 6 contiguous nucleotide 4 WO00/56906 PCT/IBOO/00317 bases. The determination of a comparison window can be carried out by using sequence alignment algorithms in order to determine an homology with the reference sequence, for example the local homology algorithm, the homology alignment algorithm, and the 5 similarity search algorithm, these algorithms also existing as computer programs, and designated by names such as GAP, BESTFIT, FASTA and TFASTA. The percentage of sequence identity is obtained by comparing the reference sequence with the box and/or nucleic acid sequence using one or more of the 10 abovementioned methods ; - "situated" means the position on a nucleic acid sequence of an identified element, as for example a "box", a restriction site, or a codon having a particular function. The position that is given by a number refers to the position of the start of the 15 element in the nucleic acid sequence, in the reading direction of the latter, i.e. in the direction 5'->3' with respect to the position of the transcription start site indicated as +1 ; - "transgenic plant" means a plant having been obtained through the application of genetic manipulation techniques, and includes 20 whole plants obtained by such techniques, their progeny, as well as plant organs, for example, but non limitatively, roots, stems, leaves and leaves, obtained by such techniques. The transgenic plants obtained according to the present invention can also have different degrees of diploidism, and can for 25 example be polyploid, diploid, and haploid ; - "propagule" means an accumulated mass or an association or an aggregation of structured or unstructured plant cells, capable of enabling the regeneration of a whole plant therefrom ; such associations can for example be in the form of explants, calli, 30 stems, leaves, roots, cuttings, and even seeds. The present applicant has taken a completely different approach to that taken by the applicant or the previously discussed PCT application. Serendipitously, the present applicant has managed to produce chimeric promoters which fill the need expressed 35 previously, and in particular, enable an increase in the degree of expression of a gene, or a nucleic acid sequence operably 5 WO00/56906 PCT/IBOO/00317 linked to said promoter, which codes for a polypeptide that it is desired to produce in a host cell, and preferably in a plant cell, with respect to the existing promoters currently in use. Furthermore, the present applicant has managed at the same time 5 to produce a family of promoters in such a way as to enable the choice of a promoter most suited to a particular task or application or an environment in which it is intended to be used, and thus is able to control the degree of expression of a gene to be expressed, or a nucleic acid sequence operably linked 10 to said promoter, that codes for a polypeptide which it is desired to produce in the host cell. Consequently, one of the objects of the present invention is a chimeric expression promoter comprising at least one nucleic acid sequence derived from a promoter of the pea plastocyanin 15 gene having the sequence identified under the number SEQ.ID01. Preferably, the chimeric promoter comprising a nucleic acid sequence derived from the promoter of the pea plastocyanin gene is selected from the group consisting of the sequences identified in the sequence listing under the numbers SEQ.IDO2, 20 SEQ.IDO3, SEQ.ID04, SEQ.ID05, SEQ.ID06, SEQ.ID07, SEQ.ID08, SEQ.ID09, SEQ.ID10, and SEQ.ID11. Furthermore, the present applicant has noticed that it is possible to build promoters according to the invention, and especially plant promoters, having an interesting promoter 25 activity, whilst at the same having a minimum of regulatory boxes, and in particular at least one "G" box, a "CAAT" box and a "TATA" box, the only condition being that the "G" box be situated upstream of the other boxes, i.e. in the 5' region of the nucleic acid sequence, and that this "G" box be 30 preferentially siutated at a certain distance, expressed in nucleotide bases, upstream from the other boxes. Thus, another object of the present invention is a chimeric expression promoter comprising a "G" box operably linked upstream of at least one "CAAT" box, one "TATA" box and a transcription 35 initiation site (indicated by +1 in the figures). More preferably, the "G" box is situated between the positions - 225 6 WO00/56906 PCT/IBOO/00317 and -65 with respect to the transcription initiation site (+1). Even more preferably, the "G" box is situated between the positions - 201 and - 115 with respect to the transcription initiation site (indicated by +1 in the figures). In the most 5 preferred embodiments, the "G" box is situated either at position - 201, or at position - 115, with respect to the transcription initiation site (indicated as position +1 in the figures). Advantageously, the "G" box is of plant origin. Preferably, the 10 "G" box is obtained from a promoter of the pea plastocyanin gene. Even more preferably, the "G" box is obtained from the petE promoter of the pea plastocyanin gene. According to a preferred embodiment of the promoters of the present invention, the promoters further comprise a "nos E like" 15 box operably or functionally linked upstream of the "G" box. According to another preferred embodiment of the invention, the promoters also comprise at least one "asl" or "asl like" box operably or functionally linked to the "G" box, and preferably two or more such boxes, arranged either contiguously or 20 separately, and most preferably four such boxes. These "asl" or "asl like" boxes may be linked both upstream and downstream of said "G" box, and preferably are linked upstream thereof. In another preferred mode of the invention, one or more of the the "asl" or "asl like" boxes can also be arranged in what is known 25 as inverse order, that is, from the 3' to the 5' direction, and preferably in inverse repeat order. According to one particularly preferred embodiment of the present invention, the promoters also comprise at least one "as2" box operably or functionally linked to the "G" box, and 30 preferably two or more such boxes, arranged either contiguously or separately, and most preferably four such boxes. These boxes may also preferably be linked both upstream and downstream of said "G" box, and more preferably are linked upstream thereof. In another preferred mode of the invention, some or all of the 35 boxes can also be arranged in what is known as inverse order, or as inverse repeats as described above. 7 WO00/56906 PCT/IBOO/00317 Finally, and even more preferably, the chimeric promoters as described above comprise at least one nucleic acid sequence selected from the group consisting of the sequences identified in the sequence listing under the numbers SEQ.ID02, SEQ.ID03, 5 SEQ.ID04, SEQ.ID05, SEQ.IDO6, SEQ.ID07, SEQ.ID08, SEQ.ID09, SEQ.ID10, and SEQ.ID11. Yet another object of the present invention is an expression cassette comprising at least one nucleic acid sequence derived from a promoter of the gene of the pea plastocyanin gene, 10 operably or functionally linked to a gene or a nucleic acid sequence coding for a polypeptide that it is desired to express, said coding nucleic acid sequence being in turn operably or functionally linked to a transcription termination nucleic acid sequence, wherein the nucleic acid sequence derived from the 15 promoter of the pea plastocyanin gene is selected from the sequences identified in the sequence listing under the numbers SEQ.ID02, SEQ.ID03, SEQ.ID04, SEQ.ID05, SEQ.ID06, SEQ.ID07, SEQ.ID08, SEQ.ID09, SEQ.ID10, and SEQ.ID11. Another object of the present invention is an isolated promoter 20 nucleic acid sequence, characterized in that the sequence is selected from the group consisting of the sequences identified in the sequence listing under the numbers SEQ.IDO2, SEQ.ID03, SEQ.ID04, SEQ.ID05, SEQ.ID06, SEQ.ID07, SEQ.ID08, SEQ.IDO9, SEQ.ID10, and SEQ.ID11. Such a sequence may be one obtained 25 through deletion, substitution, addition of one or more nucleic acids to or from the sequence identified in the sequence listing under SEQ.ID01. Yet still another object of the present invention relates to desoxynucleotide or desoxynucleoside blocks for the production 30 of promoters of promoter nucleic acid sequences as identified previously. These blocks can be : - building blocks or "directional" blocks, i.e. sequences that read in the same direction as the final promoter or promoter nucleic acid sequence sequence, which is from the 5' end of the 35 sequence towards the 3' end of the sequence; and/or - "guide" blocks, i.e. sequences whose ends include nucleotide 8 WO00/56906 PCT/IB00/00317 or nucleoside bases that complement with and overlap with the ends of the directional building blocks. Thus, and most preferably, the directional building block corresponds to at least one sequence selected from the group 5 consisting of the sequences identified in the sequence listing under the numbers SEQ.ID12, SEQ.ID13, SEQ.ID14, SEQ.ID15, SEQ.ID16, SEQ.ID17, and SEQ.ID18. Furthermore, it is preferred to use the guide blocks corresponding to at least one sequence selected from the group 10 consisting of the sequences identified in the sequence listing under the numbers SEQ.ID19, SEQ.ID20, SEQ.ID21, and SEQ.ID22. Another object of the present invention is a vector comprising a promoter, or a promoter nucleic acid sequence, capable of initiating transcription of a gene or a nucleic acid sequence 15 coding for a polypeptide that it is desired to produce, characterized in that the promoter or the promoter nucleic acid sequence corresponds to a chimeric expression promoter or to a promoter nucleic acid sequence as defined previously. Preferably, the vector is selected from the group consisting in 20 the binary vectors identified under the numbers pMRT1151, pMRT1149, pMRT1170. Yet still another object of the present invention is a process for the production of a chimeric expression promoter or an isolated promoter nucleic acid sequence such as those defined 25 previously, characterized in that it comprises the steps of : - carrying out a ligation chain reaction, designated as LCR, to produce a continuous single stranded DNA molecule from at least one directional building block desoxynucleotide or desoxynucleoside sequence selected from the group consisting in 30 the directional building blocks Si, S2, S3, S4, S5, S6, and S7 as identified in the sequence listing under the numbers SEQ.ID12, SEQ.ID13, SEQ.ID14, SEQ.ID15, SEQ.ID16, SEQ.ID17 and SEQ.ID18 respectively, and at least one desoxynucleotide or desoxynucleoside guide block for building said promoter nucleic 35 acid sequence or promoter, the guide block being selected from the group consisting in the guide sequences Gl, G2, G3, and G4 9 WO00/56906 PCT/IB00/00317 identified in the sequence listing under the numbers SEQ.ID19, SEQ.ID20, SEQ.ID21 and SEQ.ID22 respectively; - carry out a PCR amplification on the single strand obtained from the preceding step, thereby enabling the production of a 5 double stranded DNA corresponding to the chimeric expression promoter or tot the promoter nucleic acid sequence; - optionally isolating the promoter or the promoter nucleic acid sequence. Preferably, the desoxynucleotide or desoxynucleoside building 10 blocks are phosphorylated before ligation. Even more preferably, the ligation is carried out in the presence of at least one DNA ligase in a thermocycle, under the following conditions : - a first cycle of about one minute at about 94 0 C ; - eight subsequent identical cycles, each one comprising the 15 following steps : - one minute at 65oC, one minute at 570C, one minute at 520C, one minute at 480C, one minute at 43 0 C and ten minutes at 37 0 C. Another object of the present invention is a transgenic plant having stably integrated into its genome at least one promoter 20 or at least one promoter nucleic acid sequence as previously defined. Preferably, the transgenic plant is selected from dicotyledonous species, such as for example, and preferably, potato, tobacco, cotton, lettuce, tomato, melon, cucumber, peas, rapeseed, beetroot, and sunflower, and/or from monocotyledous 25 species, such as for example, and preferably, wheat, barley, oats, rice and corn. Another object of the present invention is a transgenic plant propagule, wherein propagule has the definition defined previously, and preferably the propagule is a seed. 30 Yet another object of the present invention is a cell containing a promoter or a promoter nucleic acid sequence as previously defined. Preferably, the cell is a procaryote or eucaryote cell, and even more preferably is a cell chosen from the group consisting of bacterial, insect, animal, human, fungal, algal, 35 yeast and plant cells, and most preferably is a plant cell. Among other preferred objects of the present invention, there is 10 WO00/56906 PCT/IBOO/00317 also a process for the expression of a nucleic acid sequence, or gene, coding for a polypeptide that it is desired to produce, in a cell, characterized in that it comprises the following steps : - transforming the cell with a vector comprising at least one 5 promoter or at least one promoter nucleic acid sequence as defined previously, operably linked to a nucleic acid seqeunce or gene, coding for a polypeptide to be produced, itself operably linked to a transcription terminator signal ; - culturing the cell in conditions enabling the expression of 10 the nucleic acid sequence, or gene, coding for the polypeptide. Preferably, the cell used in this method is a procaryote or eucaryote cell. Even more preferably, the celle is cell selected from the group consisting of bacterial cells, fungal cells, yeast cells, insect cells, animal cells, and plant cells, 15 and most preferably is a plant cell. Finally, another object of the present invention is a process for the production of a transgenic plant, or of a propagule, as defined previously, characterized in that the process includes the steps comprising : 20 - transforming a plant cell with a vector comprising at least one promoter or at least one promoter nucleic acid sequence as defined previously ; - selecting the plant cell having integrated the promoter or promoter nucleic acid sequence into its genome ; 25 - propagating the transformed and selected plant cell, either through culture, or by regeneration of whole chimeric or transgenic plants. BRIEF DESCRIPTION OF THE FIGURES The present invention will be better understood through the 30 following detailed description of several preferred embodiments given hereafter as best mode, but non-limiting examples, and by referring to the drawings in which : - Figures I, II and III schematically represent the structures of comparative reference molecular constructs, enabling a 35 comparison between the chimeric expression promoters of the present invention and said reference constructs. In Figure I, 11 WO00/56906 PCT/IB00/00317 the construction represented contains the reporter gene coding for 8-glucuronidase in the absence of any promoter sequence, and thereby serves as a negative control. - Figure II schematically represents a construct containing the 5 gene coding for 8-glucuronidase under the control of the CaMV double 35S promoter (d35S CaMV), also known as the 35S enhanced promoter (ep35S), which serves as a reference control for strong promoters ; - Figure III represents a construct serving as an internal 10 reference for transient expression experiments, and consists in the reporter gene coding for luciferase under control of the 35S CaMV promoter. - Figure IV schematically represents the structure of several preferred embodiments of the chimeric promoters according to the 15 present invention and derived from the whole promoter from the pea plastocyanin gene (petE prom), the latter also being represented. The promoters identified as MPrl098, MPrl097 and MPrl096 were obtained through enzymatic digestion of the whole promoter of the pea plastocyanin gene, whereas the promoters 20 identified as MPrl108, MPr1109, MPrll0, MPrlTl1 and MPr1112 were obtained through ligand based PCR (lb-PCR). The promoters MPr1143 and MPr1153 were respectively obtained through deletion of the "as-2" and "as-l" boxes of promoter MPrlI11, and through fusion of the "as-l like" and "nos enhancer like" boxes of 25 MPrl108 upstream of promoter MPrl143. All of the promoters produced were cloned into the vector pMRT1144 between the restriction sites PstI and BamHI in order to obtain transcriptional fusion with the reporter gene uidA which codes for 8-glucuronidase ; 30 - Figure V represents a graph comparing the relative promoter activities of the various constructs after transient expression in tobacco leaves. Three days after bombardment, the leaves were ground and the brute extract obtained clarified by centrifugation. The 8-glucuronidase and luciferase activities 35 were measured by fluorimetry on an aliquot of brute extract, and the ratio GUS/LUC activities determined. The histograms 12 WO00/56906 PCT/IBOO/00317 correspond to the average of the ratios for a given construct plus or minus Mean Standard Error (MSE) ; - Figure VI represents schematic graphs of a comparison of chimeric promoter activity after stable transformation of 5 tobacco plants. Samples were taken on all primary transformants at 2, 4, 6, 8 and 10 weeks after their transfer to greenhouse and P-glucuronidase activity measured from each sample, ponderated by the total protein content, producing a GUS activity in rlu/mg of protein. At each stage of developement, 10 activities were sorted by decreasing order for each series of primary transformants and compared to each other. In the various Figures, certain terms and expressions have the 15 following meanings : - uidA a sequence coding for 8-glucuronidase ; - IV2 = a patatin gene intron ; - nos term = a terminator from the nopaline synthase gene ; - 35S term = a terminator from the 35S RNA of CaMV ; 20 - B = the endonuclease restriction site BamHI ; - E = the endonuclease restriction site EcoRI ; - H = the endonuclease restriction site HindIII ; - P = the endonuclease restriction site PstI ; - Sp = the endonuclease restriction site SphI ; 25 - as-i = the activating sequence 1 from the CaMV 35S promoter ; - as-2 = the activating sequence 2 from the CaMV 35S promoter ; - nos E = the activating box from the nopaline synthase promoter ; - D = le site of restriction of l'endonucl~ase DralI : 30 - H = the endonuclease restriction site HindIII ; - P = the endonuclease restriction site PstI ; - S = the endonuclease restriction site Spel ; - Sp = the endonuclease restriction site SphI ; - CAAT = a "CAAT" box ; 35 - G = a "G" box ; - TATA = a "TATA" box ; 13 WO00/56906 PCT/IB00/00317 - +1 = the transcription initiation site ; - "like" means that the sequence is not 100% identical to the reference sequence from which the sequence obtains its name. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS 5 Example 1 1. Comparative Constructs (controls) In order to enable a comparis of the chimeric expression promoters described in this application, the uidA gene coding for 8-glucuronidase (Jefferson and al., 1986), and also 10 containing the nucleic acid sequence of the IV2 intron of the gene ST-LSI from potato patatin (Vancanneyt and al., 1990) (uidA-IV2) was placed under the control of one of the promoters and the terminator from the nopaline synthase gene (nos term). This construct was then transferred into Agrobacterium 15 tumefaciens through cloning into the plasmid vector pGEM3Z sold by Promega Corp. (Madison, USA). 1.1. Construction of a negative control identified as pMRT1144. In order to facilitate cloning, a plasmid vector derived from 20 pGEM3Z, that only possessed the "uidA-IV2/nos term" sequences, in the absence of any promoter sequence, was made. This plasmid was called pMRT1144 and served as a negative control (Fig. I). The uidA/nos term sequences were introduced into the pGEM3Z plasmid, and the uidA sequence was placed under the control of 25 the whole promoter of the pea plastocyanin gene and the nopaline synthase terminator, was isolated from 5 pg of pGA492-PpetE plasmid. The latter plasmid was obtained by cloning, in the plamsid pGA492-Pem2-uidA, the petE promoter from the pea plastocyanin gene obtained from the plasmid pKHn2 (Pwee and 30 Gray, 1993) in place of the em2 promoter (Gaubier and al., 1993), originating from the bp1221-Pem2 plasmid. The bp1221-Pem2 plasmid was digested with 20 units each of the enzymes HindIII and EcoRI for an hour at 370C. Then, the expression cassette "Pem2/uidA/nos term" was separated by 0.8% agarose gel 35 electrophoresis, electroeluted, precipitated in the presence of 1/10 volume of 3M sodium acetate at pH 4.8 and 2.5 volumes of 14 WO00/56906 PCT/IBOO/00317 absolute ethanol at -80 0 C for 30 min, centrifuged at 12000 g for 30 min, washed in 70% ethanol, dried, resuspended in water and inserted in between the sites HindIII and EcoRI of the plasmid pGA492 (An, 1986). Ligation was carried out in the presence of 5 1.0 pl of T4 10X DNA ligase buffer (Amersham) and 2.5 units of T4 DNA ligase (Amersham) at 14 0 C for 16 hours. Viable and competent Escherichia coli DH5abacteria were transformed (Hannahan, 1983). The plasmid DNA of the obtained clones, as selected on Luria-Bertani medium (LB, bactotryptone 10 g/l, 10 yeast extract 5 g/l, NaCl 10 g/l, Agar 15 g/l) supplemented with tetracycline (12 mg/l), was extracted according to the alkaline lysis method of Birnboim and Doly (Birnboim & Doly, 1983) and analyzed by enzymatic digestion. Starting from the thus obtained pGA492-Pem2-uidA plasmid, the 15 promoter Pem2 was deleted via double digestion by HindIII and XbaI. The plasmid fragment of interest was separated by 0.8% agarose gel electrophoresis, electroeluted, precipitated in the the presence of 1/10 volume of 3M sodium acetate pH 4.8 and 2.5 volumes absolute ethanol at -80°C for 30 min, centrifuged at 20 12000 g for 30 min, washed in 70% ethanol, dried, and subjected to the action of a Klenow fragment of DNA polymerase I (New England Biolabs) for 30 min at 37 0 C according to the recommendation of the manufacturer. Then, it was deproteinized by extraction with a volume of phenol, then a volume of phenol : 25 chloroform : isoamyl alcohol (25:24:1 v/v/v) and finally one volume of chloroform : isoamyl alcohol (24:1 v/v), precipitated in the presence of 1/10 volume of 3M sodium acetate pH 4.8 and 2.5 volumes of absolute ethanol at -80 0 C for 30 min, then centrifuged at 12000 g for 30 min, washed in 70% ethanol, dried, 30 and resuspended in water. Then it was dephosphorylized for lh at 37 0 C with the help of 10 units of calf intestine alcaline phosphatase (Boehringer Mannheim) according to the recommendation of the manufacturer, deproteinized through extraction with one volume of phenol, then one volume of phenol 5 : chloroform : isoamyl alcohol (25:24:1 v/v/v) and finally one volume of chloroform : isoamyl alcohol (24:1 v/v), precipitated 15 WO00/56906 PCT/IB00/00317 in the presence of 1/10 volume 3M sodium acetate pH 4.8 and 2.5 volumes of absolute ethanol at -800C for 30 min then centrifuged at 12000 g for 30 min, washed in 70% ethanol, dried then resuspended in water. The resulting plasmid was called 5 pGA492APem2. In parallel, the petE promoter (818 base pairs), which corresponds to the promoter of the pea plastocyanine gene, was obtained from the plamsid pKHn2 by digestion with NcoI for 1 h at 37 0 C. The 828 bp promoter fragment was isolated on 0.8% gel 10 agarose, electroeluted, precipitated in the presence of 1/10 volume of 3M sodium acetate pH 4.8 and 2.5 volumes of absolute ethanol at -80 0 C for 30 min, centrifuged at 12000 g for 30 min, washed in 70% ethanol, dried, resuspended in water, then subjected to the action of 5 units of Mung Bean nuclease 15 (New England Biolabs) for 30 min at 30 0 C according to the recommendations of the manufacturer, deproteinized by extraction with one volume of phenol, then one volume fo phenol : chloroform : isoamyl alcohol (25:24:1 v/v/v) and finally one volume of chloroform : isoamyl alcool (24:1 v/v), precipated in 20 the presence 1/10 volume of 3M sodium acetate pH 4.8 and 2.5 volumes of absolute ethanol at -80 0 C for 30 min then centrifuged at 12000 g for 30 min, washed in 70% ethanol, dried, then resuspended in water. This promoter fragment was inserted into the plasmid pGA492APem2, described previously, in the presence 25 of 1.0 pl of T4 10X DNA ligase buffer (Amersham) and 2.5 units of T4 DNA ligase (Amersham) at 14 0 C for 16 h. Viable ad competent Escherichia coli DH5x bacteria, were transformed. The plasmid DNA of the obtained clones, selected on LB medium supplemented with tetracycline (12 mg/l), was extracted 30 according to the alkaline lysis method and analyzed by enzymatic digestion. The resulting plamsid was designated pGA492-petE prom. IN order to isolate the expression cassette "petE prom/uidA/nos term", 5 pg of the plasmid pGA492-petE prom were digested by 35 PstI (at a 5' site on the plastocyanin gene promoter) and EcoRI (at a 3' site on the terminating sequence) for 1 h at 37 0 C, 16 WO00/56906 PCT/IB00/00317 subjected to 0.8% agarose gel electrophoresis and purified on a Qiaquick affinity column (Qiagen, Hilden, Allemagne) according to the manufacturer's recommendations. Meanwhile, 500 ng of pGEM3Z plasmid were simultaneously digested for 1 h at 37 0 C by 5 EcoRI and PstI (restriction sites present in a multiple cloning site or polylinker), subjected to 0.8% gel electrophoresis, then purified on a Qiaquick affinity column. Ligation was carried out with 50 ng of the vector pGEM3Z-PstI/EcoRI and 50 ng of the expression cassette "petE 10 prom/uidA/nos term" for one night at 18 0 C in a reaction medium of 12 pl in the presence of 1.2 pl of T4 10X DNA ligase buffer (New England Biolabs) and 400 units of T4 DNA ligase (New England Biolabs). Previously prepared viable and competent Escherichia coli DH5x, were transformed by mixing with the 15 ligation reaction mixture. The plasmid DNA of the obtained clones, selected on LB medium supplemented with ampicillin (50 mg/l), was extracted according to the alkaline lysis method and was analyzed by enzymatic digestion. The obtained plasmid was designated pGEM3Z-petE prom. ?0 In order to insert the 192 bp IV2 intron originating from the potato patatin gene into the uidA coding sequence, an internal portion of this gene (a SnaBI / BstBI 710 bp fragment in pGEM3Z-petE prom) was excised then replaced by the equivalent sequence containing the IV2 intron (a SnaBI / BstBI 902 bp !5 fragment). To accomplish this, the plasmid pGEM3Z-petE prom was digested for 1 h at 37 0 C by SnaBI (restriction site located at the +383 bp position upstream of the ATG initiator codon of the uidA gene) then for 1 h at 65 0 C by BstBI (restriction site located at the +1093 bp position). The plasmid comprising the 0 710 bp deletion was isolated by 0.8% agarose gel electrophoresis, then purified on a Qiaquick affinity column. The BstBI/SnaBI 902 bp fragment corresponding to the IV2 intron sequence followed by the uidA sequence stretching from position 383 to 1093 bp, was isolated and purified from the plasmid .5 pSCV1.2-GI. This plamsid derives from plamsid pSCV1.2, which in turn derives from plamsid pSCV1 constructed by G.A. Edwards in 17 WO00/56906 PCT/IBOO/00317 1990 according to the methods habitually used in cloning and well known to the skilled person. The binary plamsid pSCVI.2 was obtained by cloning the HindIII fragment bearing the expression cassette "35S prom / nptII / nos term" (Fromm and al., 1986) at 5 the HindIII site in pSCV1. The expression cassette "35S prom / GUS-IV2 / 35S term" was obtained by digesting the plamsid p35S GUS INT with HindIII for 1 h at 370C as described by Vancanneyt and al. (1990). The DNA fragment corresponding to the expression cassette was isolated on 0.8% agarose gel, electroeluted then 10 precipitated in the presence of 1/10 volume of 3M sodium acetate at pH 4.8 and 2.5 volumes of absolute ethanol at -80'C for 30 min then, centrifuged at 12000 g for 30 min, washed in 70 % ethanol, dried and resuspended in water. The protruding 5' extremities of this fragment were blunted with the Klenow 15 fragment of DNA polymerase I (New England Biolabs) for 30 min at 370C according to the recommendations of the manufacturer, and the fragment was deproteinized by extraction with a volume of phenol, then a volume of phenol : chloroform : isoamyl alcohol (25:24:1 v/v/v) 20 and finally a volume of chloroform : isoamyl alcohol (24:1 v/v), precipitated in the presence of 1/10 volume of 3M sodium acetate at pH 4.8 and 2.5 volumes of absolute ethanol at -800C for 30 min then, centrifuged at 12000 g for 30 min, washed in 70% ethanol, dried and finally ligated with 20 ng of the plasmid 25 pSCV1.2 previously digested with SmaI for 1 h at 25oC, in the presence of 1.0 pl of T4 10X DNA ligase buffer (Amersham) and 2.5 units of T4 DNA ligase (Amersham) at 140C for 16 h. Previously prepared viable and competent Escherichia coli DH50 bacteria were transformed. The plamsid DNA of the obtained 30 clones, selected on LB medium supplemented with ampicillin (50 mg/l), was extracted according to the alkaline lysis method and analyzed by enzymatic digestion. Five micrograms (5 pg) of pSCV1.2-GI plasmid were digested for 1 h at 370C by SnaBI (restriction site located at the position 35 +383 bp upstream of the ATG initiator codon of the uidA gene) then for 1 h at 650C by BstBI (site located at the +1285 bp 18 WO00/56906 PCT/IBOO/00317 position). The 902 bp fragment was isolated by 1.0% agarose gel electrophoresis, then purified on a Qiaquick affinity column. The ligation was carried out with 20 ng of vector pGEM3Z-petE prom BstBI/SnaBI and 80 ng of the 902 bp fragment BstBI/SnaBI, 5 for 1 night at 180C in a 10 pl reaction medium in the presence of 1.0 pl of T4 10X DNA ligase (New England Biolabs) and 400 units of T4 DNA ligase (New England Biolabs). Viable and competent Escherichia coli DH5 bacteria, were transformed by half of the ligation reaction mixture. The plamsid DNA obtained 10 from the clones, selected on LB medium supplemented with ampicillin (50 mg/l), was extracted according to the alkaline lysis method and was analyzed by enzymatic digestion. The obtained plasmid was designated pGEM3Z-petE prom/IV2. In order to eliminate the promoter sequence corresponding to the 15 818 bp fragment (petE) of the plasmid pGEM3Z-petE prom/IV2, the latter was digested for 1 h at 370C by BamHI then, for 1 h at 370C by PstI, isolated by 0.8% agarose gel electrophoresis, then purified on a Quiaquick affinity column. The protruding 5' extremities of this plasmid were rendered blunt by using 20 utilisant Pfu DNA polymerase (Stratagene, La Jolla, USA) according to the recommendations of the supplier. The ligation was carried out with 10 ng of the thus modified plasmid for 1 night at 180C in a reaction volume of 12 pl, in the presence of 1.2 pl of T4 10X DNA ligase (New England Biolabs) and 400 units 25 of the enzyme T4 DNA ligase (New England Biolabs). Viable and competent Escherichia coli DH5 were transformed with half of the ligation reaction mixture. The plamsid DNA of the obtained clones, selected on LB medium supplemented with ampicillin (50 mg/l), was extracted according to the alkaline lysis method, 30 analyzed by enzymatic digestion, and verified by sequencing according to the method of Sanger et al. (1977). The plasmid obtained was designated pMRT1144 (Fig. I). 1.2. Construction of the positive control promoter MPr1092. In order to hava available a reference promoter sequence, the 35 "double 35S" cauliflower mosaic virus promoter (CaMV D35S prom), was placed upstream of the uidA-IV2/nos term sequence. The 19 WO00/56906 PCT/IB00/00317 plasmid pMRT1092 (Fig. II) is a result of the following cloning steps : To start with, the 192 bp IV2 intron of the potato patatin gene was inserted into the uidA coding sequence at the +383 bp 5 position as described under section 1.1. A one microgram amount (1 pg) of bp1221 plasmid (Clontech, CA, USA) was digested for 1h30 at 37 0 C by SnaBI, then for 1h30 at 650C by BstBI. The plasmid deleted of the 710 bp fragment was isolated by 0.8% agarose gel electrophoresis, then purified on a Quiaquick 10 affinity column. A twenty nanogram (20 ng) amount of bp1221 BstBI/SnaBI vector and 80 ng of the 902 bp BstBI/SnaBI fragment originating from pSCV1.2-GI as previously described, were ligated for 1 night at 180C in a 10 pl reaction volume, in the presence of 1 pl of T4 15 10X DNA ligase (New England Biolabs) and 400 units of T4 DNA ligase (New England Biolabs). Viable and competent Escherichia coli DH5a were transformed with hald of the ligation reaction mixture. The plasmid DNA of the obtained clones, selected on LB medium supplemented with ampicillin (50 mg/l), was extracted 20 according to the alkaline lysis method and analyzed by enzymatic digestion. The obtained plasmid was designated bpI221/uidA-IV2. In a second step, the sequence of the CaMV35S promoter present in the bp1221/uidA-IV2 plasmid was replaced by the "CaMV D35S" 25 sequence. This was achieved by digesting the bp1221/uidA-IV2 plamsid for 10h30 at 370C with 10 units of HindIII, then the sticky ends were rendered blunt by the action of the Klenow fragment of DNA polymerase I (New England Biolabs) for 30 min at 370C according to the recommendations of the manufacturer. After 30 purification of the product of this reaction on a Qiaquick affinity column, the DNA was digesteed for une night at 370C with 10 units of BamHI. The plasmid fragment, corresponding to the vector deleted of the 828 bp promoter CaMV 35S fragment, was isolated by 0.8% agarose gel electrophoresis, then purified on a 35 Quiaquick affinity column. CaMV D35S prom was obtained from the plasmid pJIT163D. This 20 WO00/56906 PCT/IB00/00317 derives from the plasmid pJIT163 which in turn derives from the plasmid pJIT160 (Guirineau and Mullineaux, 1993). The plasmid pJIT163 has an ATG codon between the HindIII and SalI sites of the polylinker. In order to delete this ATG and thereby obtain 5 the plasmid pJIT163D, the plasmid DNA of pJIT163 was digested by HindIII and SalI, purified by 0.8% agarose gel electrophoresis, electroeluted, precipitated in the presence of 1/10 volume of 3M sodium acetate at pH 4.8 and 2.5 volumes of absolute ethanol at -800C for 30 min, centrifuged at 12000 g for 30 min, washed 10 in 70% ethanol, dried, subjected to the action of the Klenow fragment of DNA polymerase I (New England Biolabs) for 30 min at 37 0 C according to the recommendations of the manufacturer, deproteinized by extraction with a volume of phenol, then a volume of phenol : chloroform : isoamyl alcohol (25:24:1 v/v/v) 15 and finally a volume of chloroform : isoamyl alcohol (24:1 v/v), precipitated in the presence of 1/10 volume of 3M sodium acetate at pH 4.8 and 2.5 volumes of absolute ethanol at -80 0 C for 30 min, then centrifuge at 12000 g for 30 min, washed in 70 % ethanol, dried and finally ligated in the presence of 1.0 pl of 20 T4 10X DNA ligase (Amersham) and 2.5 units of T4 DNA ligase (Amersham) at 14oC for 16 h. Viable and competent Escherichia coli DH5a bacteria were transformed. The plasmid DNA of the obtained clones, selected on LB mdeium supplemented with (50 mg/l), was extracted according to the alkaline lysis method and 25 analyzed by enzymatic digestion. Ten micrograms (10pg) of plasmid pJIT163D were digested for 10h30min at 37 0 C with 10 units of KpnI (site siutated in 5' of the promoter), then the sticky ends were rendered blunt by the action of 6 units of T4 DNA polymerase (New England Biolabs) for 30 30 min at 37 0 C according to the recommendations of the manufacturer. After purification of the product of this reaction on a Qiaquick affinity column, the DNA was digested for one night at 37oC with 10 units of BamHI. The resulting 761 bp DNA fragment, corresponding to the promoter CaMV D35S was isolated 35 by 1.0 % gel agarose electropheresis, then purified on a Quiaquick affinity column. 21 WO00/56906 PCT/IBOO/00317 The reaction mixture containing 10 ng of plasmid vector, 100 ng of the 761 bp fragment, 1.0 pl of T4 10X DNA ligase (New England Biolabs) and 400 units of T4 DNA ligase (New England Biolabs) was subjected to ligation in 10 pl for one night at 180C. Viable 5 and competent Escherichia coli DH5 were trasnformed with half of the ligation reaction mixture. The plasmid DNA of the obtained clones, selected on LB media supplemented with ampicillin (50 mg/l), was extracted according to the alkaline lysis method and analyzed by enzymatic digestion. The plasmid 10 obtained was designated pMRT1092 (Fig. II). 1.3. Description of the reference plasmid pCaMV35Sluc. The plasmid serving as an internal reference for transient expression is pCaMV35Sluc (Torrent et al., 1997) which contains the expression cassette of the luciferase reporter gene (luc) 15 under the control of the RNA 35S Cauliflower Mosaic Virus promoter and terminator. Example 2. Construction of plasmids containing deleted promoter sequences from the pea plastocyanine gene. 20 The whole promoter of the pea plastocyanin gene (Last and Gray, 1989) corresponds to a sequence of 834 bp (SEQ. ID01) starting from position -771 bp to position + 63 bp, and in which several potential regulatory sequences have been identified (numbers given with respect to the 5' end towards the 3' end of the 25 sequence, and with respect to the transcription initiation site +1, Fig. IV) : - a series of inverted repeats, stretching from positions -734 to -607 bp, - a 20 bp box (as-i like) having a certain similarity to the 30 activating sequence 1 (as-1) present in the CaMV 35S promoter, and stretching from position -579 to position -559 bp, - a 21 bp box (nos enhancer like) having a certain homology to an activating sequence present in the promoter of the nopaline synthase gene of Agrobacterium tumefaciens, and stretching from 35 position -540 to -519 bp, - an 8 bp "G" box, stretching from position -201 to position 22 WO 00/56906 PCT/IB00/00317 -193 bp, - a 14 bp box, stretching from position -83 to position -69 bp, and having a certain similarity to type III boxes found in the promoters of higher plants, 5 - a "CAAT" box, at position -63 - a "TATA" box, at position \37 - the transcription initiation site +1 (position 1) - a 5' untranslated region stretching from the +1 position to the 63 bp position. 10 The plasmid pGEM3Z-petE prom was obtained as described above in section 1.1 of example 1. It corresponds to the plasmid pGEM3Z containing the reporter gene uidA-IV2 under the control of the whole of the pea plastocyanin gene (petE prom, Fig IV, SEQ.ID01), and serves as a reference promoter for all of the 15 constructions based on the plastocyanin promoter. In order to study the effects of the different elements, deletions in the 5' region of petE prom were carried out by enzymatic digestion. 2.1. Construction of the promoter MPr1097. 20 The promoter MPrl097 derives from the petE promoter by a 5' deletion of the inverted sequence repeats, as well as the as-i like box borne on the 212 bp Sphl fragment (Fig. IV). In order to do this, five micrograms (5 pg) of the plasmid pGEM3Z-petE/IV2 were digested for 2 h at 37 0 C with 20 units of 25 SphI enzyme, isolated by 0.8% agarose gel electrophoresis, then purified on a Qiaquick affinity column. The ligation was carried out with 25 ng of the thus modified plasmid for one night at 18 0 C in a 10 pl reaction mixture, in the presence of 1 pl of T4 10X DNA ligase (New England Biolabs) 30 and of 400 units of T4 DNA ligase (New England Biolabs). Viable and competent Escherichia coli DH5a cells were transformed with half the ligation reaction mixture. The plasmid DNA of the obtained clones, selected on LB media supplemented with ampicillin (50 mg/1), was extracted according to the alkaline 35 lysis method, and analyzed by enzymatic digestion. The plasmid obtained was designated pMRT1097 and the promoter sequence 23 WO00/56906 PCT/IB00/00317 designated MPrl097 (SEQ.ID02) was verified by sequencing. 2.2. Construction of the promoter MPr1096. The promoter MPrl096 derives from the petE promoter by a 5' deletion of the inverted repeat sequences, the "as-i like" 5 elements and the "nos enhancer like" element borne by two Spel fragments of 403 bp and 105 bp respectively (Fig. IV). In order to do this, 5 micrograms (pg) of plasmid pGEM3Z-petE /IV2 were digested for 2 h at 37oC with 20 units of Spel enzyme, isolated by 0.8% agarose gel electrophoresis, and then purified on a 10 Qiaquick affinity column. The ligation was carried out with 25 ng of the thus modified plasmid for 1 night at 18 0 C in a 10 pl reaction mixture, in the presence of 1 pl of T4 10X DNA ligase (New England Biolabs) and of 400 units T4 DNA ligase (New England Biolabs). Viable and 15 competent Escherichia coli DH5x cells were transformed with half of the ligation reaction mixture. The plamsid DNA of the obtained clones, selected on LB media supplemented with ampicillin (50 mg/l), was extracted according to the alkaline lysis method, and analyzed by enzymatic digestion. The plasmid 20 obtained was designated pMRT1096 and the promoter sequence MPrl096 (SEQ.ID03) was verified by sequencing. 2.3. Construction of the promoter MPr1098. In order to obtain a reference minimal promoter sequence based on the petE promoter, the 207 bp promoter MPrl098 was 25 constructed to contain only the "TATA" and "CAAT" boxes (Fig. IV). This was accomplished by digesting five micrograms (5 pg) of the plasmid pGEM3Z-petE /IV2 for 2 h at 37oC with 1.5 units of DraIII enzyme (1 site present at position -128) and 15 units of 30 PstI enzyme (1 site present in the 5' region of the promoter at position -759 bp). The plasmid thus deleted of the 631 bp fragment PstI/DraIII situated in the 5' region of the petE promoter was isolated by 0.8% agarose gel electrophoresis, then purified on a Quiaquick affinity column. The sticky ends of this 35 fragment were rendered blunt by the action of 6 units of T4 DNA polymerase (New England Biolabs) for 30 min at 37oC according to 24 WO00/56906 PCT/IBOO/00317 the recommendations of the manufacturer. After purification of the product of this reaction on a Qiaquick affinity column, ligation was carried out with 25 ng of the thus modified plasmid for 1 night at 180C in a 10 pl reaction mixture, in the presence 5 of 1 pl of T4 10X DNA ligase (New England Biolabs) and of 400 units of T4 DNA ligase (New England Biolabs). Viable and competent Escherichia coli DH5 cells were transformed with half the ligation reaction mixture. The plasmid DNA of the obtained clones, selected on LB media supplemented with ampicillin (50 10 mg/1), was extracted according .to the alkaline lysis method and analyzed by enzymatic digestion. The plasmid obtained was dsignated pMRT1098 and the promoter sequence MPrl098 was verified by sequencing (SEQ.ID04). This sequence corresponds to the minimal pea plastocyanin promoter (Fig. IV). 15 Example 3. Construction of plasmids containing chimeric promoter sequences. In addition to the promoters obtained by deletion of certain 5' regions, a series of promoters was synthesized that started out from the basic minimal promoter Mprl098 using the lb-PCR 20 technique which combines a ligation chain reaction, designated LCR (Barany, 1991) and producing a single stranded continuous DNA with the help of "directional" oligodesoxynucleotides, with a PCR reaction leading to a double stranded DNA product. 3.1. Construction of the promoter MPr1108. 25 The promoter MPr1108 (Fig. IV) was created by fusing the 72 bp sequence stretching from position -641 bp to position -569 bp of the petE promoter (SEQ. ID01), and bearing the "as-l like" and "nos enhancer like" boxes, to the 187 bp minimal promoter sequence of MPrl098 (position -128 to +59 bp, SEQ.IDO4) using 30 the lb-PCR technique. Continuous single stranded DNA was formed with the help of the following directional oligodesoxynucleotides : - S1 = 5' TTCCCTTCAAACACATACAAATTCAGTAGAGAAGAAACTCATTACTCTTGAGAAACCTAG 35 AGGATCCCCG 3' (SEQ.ID12) - S2 = 25 WO 00/56906 PCT/IB00/00317 5' CACAAAAACCCAATCCACATCTTTATCATCCATTCTATAAAAAATCACCTTCTGTGTGTC TCTCTTTCGA 3' (SEQ.ID13) - s3 = 5 5' CATAATTTGAACACTCTGTGGCACATCTACATTATCTAAATCACATATTCTTCCACACAT CTTAGCCA 3' (SEQ.ID14) - S4 = 5' GGAATCTGCAGTTGAACACGTACAAACTTACGTCATTTGTGCATGCAGAAGCATAGAGCT GAGCACACAATT 3' (SEQ.ID15) 10 One hundred picomole (100 pmol) of the Si, S2 and S3 oligodesoxynucleotides were 5' phosphorylated by the action of 15 units of kinase (Amersham) in the presence of 5 pl of 10X kinase (Amersham) and 500 pmol of ATP (Sigma), for 30 minutes at 37 0 C. The phosphorylated oligodesoxynucleotides were purified by 15 extraction with a volume of phenol, then a volume of phenol : chloroform : isoamyl alcohol (25:24:1 v/v/v) and finally a volume of chloroform : isoamyl alcohol (24:1 v/v), before being precipitated with 1/10 volume of 3M sodium acetate at pH 4.8 and 2.5 volumes of absolute ethanol at -80 0 C for 20 min then 20 centrifuged at 16060 g for 30 min. The precipitated oligodesoxynucleotides were washed with 70% ethanol, dried, then resuspended in water at a concentration of 10 pmol/pl. In order to link up the "directional" oligodesoxynucleotides, the following "guide" oligodesoxynucleotides were used : 25 - Gl= 5' TGTGTTTGAAGGGAATCGAAAGAGAGACACA 3' (SEQ.ID18) - G2= 5' GATTGGGTTTTTGTGTGGCTAAGATGTGTG 3' (SEQ.ID19) - G3= 5' CAGAGTGTTCAAATTATGAATTGTGTGCTCAGC 3' (SEQ.ID20) In order to carry out the LCR reaction, 10 pmol of the phosphorylated S1, S2, S3 and S4 "directional" 30 oligodesoxynucleotides were ligated in the presence of 10 pmol of the Gl, G2 and G3 "guide" oligodesoxynucleotides, 5 pl of Taq 10X DNA ligase (New England Biolabs) and 40 units of Taq DNA Ligase (New England Biolabs). The ligation reaction was carried out in a GeneAmp PCR System 9700 thermocycle (Perkin Elmer, 35 Norwalk, USA). The reaction involved the steps consisting of one cycle for one minute at 94 0 C, and of 8 identical subsequent 26 WO00/56906 PCT/IB00/00317 cycles, each consisting in the following : one minute at 65oC, one minute at 57 0 C, one minute at 52 0 C, one minute at 48 0 C, one minute at 43 0 C, and finally ten minutes at 37 0 C. Next, the ligation reaction mixture was purified on a Qiaquick affinity 5 column according to the recommendations of the supplier. Finally, PCR amplification of the obtained single stranded DNA was carried out in a GeneAmp PCR System 9700 thermocycle in the presence 100 pmol of each of the oligodesoxynucleotide probes 5' GGAATCTGCAGTTGAACACGT 3' and 5 CGGGGATCCTCTAGGTTTCT 3', 10 50 nmol of each of the dNTP, 10 pl Vent 10X DNA polymerase buffer (New England Biolabs), and 2 units of Vent DNA polymerase (New England Biolabs). The DNA was denatured for 5 min at 94oC, subjected to 25 cycles each consisting of a 30 second denaturizing step at 95oC, of a 30 second hybridizing step at 15 560C, and of one minute of elongation at 720C, then elongation at 72 0 C was continued for 5 min. The DNA fragments of the reaction mixture were digested with 20 units of BamHI for 45 min at 370C, then by 20 units of PstI for 1 h at 37 0 C, and finally purified on a Qiaquick affinity column. 20 They were inserted into the plasmid pGEM3Z-petE /IV2 that had been digested with BamHI enzyme for 1 h at 370C, then with PstI enzyme for 1 h at 37oC, and subjected to 0.8% agarose gel electrophoresis, purified on a Quiaquick affinity column, dephosphorylated for 1 h at 37 0 C in the presence of 12 pl of 25 "buffer 3" 10X (New England Biolabs) and of 5000 units of caclf gut alkaline phosphatase (CIP, New England Biolabs), and finally purified on a Quiaquick affinity column. In order to carry out ligation, 25 ng of of the plasmid as treated above were contacted with 100 ng of the DNA fragments obtained by PCR, in 30 the presence of 1.2 pl of T4 10X DNA ligase buffer (New England Biolabs) and 400 units T4 DNA ligase (New England Biolabs) for 1 night at 180C. Viable and competent Escherichia coli DH5a cells were transformed with half of the ligation reaction mixture. The DNA of the obtained clones, selected on LB media supplemented 35 with ampicillin (50 mg/l), was extracted according to the alkaline lysis method, and analyzed by enzymatic digestion. Two 27 WO00/56906 PCT/IBOO/00317 plasmids pMRT1108 and pMRT1109 resulting therefrom were sequence. The plasmid pMRT1108 contains the expected promoter (SEQ.ID05), whereas the plasmid pMRT1109 bears the promoter sequence MPrlI109 (SEQ.IDO6) which differs from MPrlI08 by a 5 deletion of 33 bp in the 5' untranslated region, 11 bp upstream of position +1 (Fig. IV). 3.2. Construction of the promoter MPr111O. The promoter MPr1lI0 was created by inserting, at position -99 bp of the MPrl098 promoter (SEQ.ID04), a block of 18 bp 10 containing a "G" box (stretching from positions -204 bp to -186 bp of the petE promoter, SEQ.ID01) and by fusing to this modified minimal promoter minimal a sequence of 44 bp from the RNA 35S cauliflower mosaic virus promoter (CaMV) containing the as-2 and as-i elements (Lam, 1989 ; Lam and al., 1989) (Fig. 15 IV). MPrllO was synthesized by the lb-PCR technique. The continuous single stranded DNA was formed with the help of the following "directional" oligodesoxynucleotides : - S1 = 5' TTCCCTTCAAACACATACAAATTCAGTAGAGAAGAAACTCATTACTCTTGAGAAACCTAG 20 AGGATCCCCG 3' (SEQ.ID12) - S2 = 5' CACAAAAACCCAATCCACATCTTTATCATCCATTCTATAAAAAATCACCTTCTGTGTGTC TCTCTTTCGA 3' (SEQ.ID13) 25 - S5 = 5' CTGTGGCACATCTACATTATCTAAATCTAAGCCACGTCGGAGGATAACATATTCTTCCAC ACATCTTAGCCA 3' (SEQ.ID16) - S6 = 5' CATGCTGCAGACTAGTGGATTGATGTGATATCTCCACTGACGTAAGGGATGACGCATGCC 30 ACT 3' (SEQ.ID17) One hundred picomole (100 pmol) of the SI, S2 and S5 oligodesoxynucleotides were 5' phosphorylated with the help of 15 units of kinase (Amersham) in the presence of 5 pl of 10X kinase buffer (Amersham) and 500 pmol of ATP (Sigma), for 30 min 35 at 37 0 C. The phosphorylated oligodesoxynucleotides were purified by extraction with a volume of phenol, then a volume of phenol : 28 WO00/56906 PCT/IB00/00317 chloroform : isoamyl alcohol (25:24:1 v/v/v) and finally a volume of chloroform : isoamyl alcohol (24:1 v/v), before being precipitated with 1/10 volume of 3M sodium acetate at pH 4.8 and 2.5 volumes absolute ethanol at -80 0 C for 20 min then 5 centrifuged at 16060 g for 30 min. Les precipitated oligodesoxynucleotides were washed in 70% ethanol, dried, then resuspended in water at une concentration of 10 pmol/pl. In order to link up the "directional" oligodesoxynucleotides, the following "guide" oligodesoxynucleotides were used : 10 - Gl= 5' TGTGTTTGAAGGGAATCGAAAGAGAGACACA 3' (SEQ.ID19) - G2= 5' GATTGGGTTTTTGTGTGGCTAAGATGTGTG 3' (SEQ.ID20) - G4= 5' TGTAGATGTGCCACAGAGTGGCATGCGT 3' (SEQ.ID22) In order to carry out the LCR reaction, 10 pmol of the phosphorylated "directional" oligodesoxynucleotides Si, S2, S5 15 and S6 were ligated in the presence of 10 pmol of the "guide" oligodesoxynucleotides Gl, G2 and G4, 5 pl of the Taq 10X DNA ligase buffer and 40 units of Taq DNA Ligase (New England Biolabs). The ligation reaction was carried out in a GeneAmp PCR System 9700 thermocycle (Perkin Elmer, Norwalk, USA). It was 20 composed of a one minute cycle at 94 0 C, and of 8 identical cycles each comprising the following steps : 1 min at 65 0 C, 1 min at 57 0 C, 1 min at 52 0 C, 1 min at 48 0 C, 1 min at 43 0 C, and finally 10 min at 37 0 C. then, the ligation reaction mixture was purified on a Qiaquick column according to the supplier's 25 recommendations. Finally, PCR ammplification of the single stranded DNA obtained previously was carried out dans in a GeneAmp PCR System 9700 thermocycle in the presence of 100 pmol of each of the following oligodesoxynucl6otide probes 5' CATGCTGCAGACTAGTGGATT 3', and 30 5' CGGGGATCCTCTAGGTTTCT 3', of 50 nmol of each of the dNTP, of 10 pl of Vent 10X DNA polymerase buffer(New England Biolabs), and of 2 units Vent DNA polymerase (New England Biolabs). The DNA was denatured for 5 min at 94 0 C, subjected to 25 cycles each composed of 30 sec of a denaturing step at 95 0 C, of 30 sec of a 35 hybridization step at 56 0 C, and of 1 min of elongation at 720C, then elongation at 72 0 C was continued for 5 min. 29 WO00/56906 PCT/IB00/00317 The DNA fragments of the reaction mixture were digested with 20 units of BamHI enzyme for 45 min at 37 0 C then with 20 units of PstI enzyme for 1 h at 37 0 C, and finally purified on a Qiaquick column. They were inserted into the plasmid pGem3Z-petE /IV2 5 which had been previously digested by BamHI enzyme for 1 h at 370C and then by PstI enzyme for 1 h at 370C, subjected to 0.8% agarose gel electrophoresis, purified on a Quiaquick affinity column, dephosphorylated for 1 h at 37oC in the presence of 12 pl of "Buffer 3" 10X (New England Biolabs) and of 5000 units of 10 calf intestine alkaline phosphatase (CIP, New England Biolabs), and finally purified on a Quiaquick affinity column. In order to carry out the ligation, 25 ng of the plasmid treated as described above were brought into contact with 100 ng of the DNA fragments obtained by PCR, in the presence of 1.2 pl of T4 10X 15 DNA ligase buffer (New England Biolabs) and 400 units of T4 DNA ligase (New England Biolabs) for 1 night at 180C. Previously prepared viable and competent Escherichia coli DH5c cells were transformed with half of the ligation reaction mixture. The DNA from the obtained clones, selected on LB media supplemented with 20 ampicillin (50 mg/l), was extracted according to the alkaline lysis method and was analyzed by enzymatic digestion. The promoter sequence MPr1l10 borne by the plasmid pMRT1110 was verified by sequencing (SEQ.IDO7). 3.3. Construction of the promoter MPr1111. 25 Th promoter MPr1111 was created by inserting an 18 bp element containing a "G" box (stretching from positions -204 bp to \186 bp of the petE promoter, SEQ.ID01) at position -99 bp of MPrl098 (SEQ.ID04), and by fusing into this minimal promoter a sequence of 58 bp corresponding to a duplication of the as-2 30 element (Lam and Chua, 1989) and the as-i element (Lam et al., 1989) of the CaMV 35S. MPrllI1 (Fig. IV) was synthesized by the lb-PCR technique as described previously. The single stranded continuous DNA was generated using the following "directional" oligodesoxynucleotides : 35 - SI = 5' TTCCCTTCAAACACATACAAATTCAGTAGAGAAGAAACTCATTACTCTTGAGAAACCTAG 30 WO00/56906 PCT/IB00/00317 AGGATCCCCG 3' (SEQ.ID12) - S2 = 5' CACAAAAACCCAATCCACATCTTTATCATCCATTCTATAAAAAATCACCTTCTGTGTGTC TCTCTTTCGA 3' (SEQ.ID13) 5 - SS = 5' CTGTGGCACATCTACATTATCTAAATCTAAGCCACGTCGGAGGATAACATATTCTTCCAC ACATCTTAGCCA 3' (SEQ.ID16) - S7 = 5' CATGCTGCAGACTAGTGATTGATGTGATATCAAGATTGATGTGATATCTCCACTGACGTA 10 AGGGATGACGCATGCCACT 3' (SEQ.ID18) One hundred picomole (100 pmol) of the SI, S2 and S5 oligodesoxynucleotides were phosphorylated in the 5' region through the use of 15 units of kinase (Amersham) in the presence of 5 pl of 10X kinase buffer (Amersham) and 500 pmol of ATP 15 (Sigma), for 30 min at 370C. Les phosphorylated oligodesoxynucleotides were purified by extraction with a volume of phenol, then a volume of phenol : chloroform : isoamyl alcohol (25:24:1 v/v/v) and finally a volume of chloroform: isoamyl alcohol (24:1 v/v), before being precipitated by 20 1/10 volume 3M sodium acetate at pH 4.8 and 2.5 volumes of absolute ethanol at -80oC for 20 min then centrifuged at 16060 g for 30 min. The precipitated oligodesoxynucleotides were washed in 70% ethanol, dried, then resuspended in water at a concentration of 10 pmol/pl. 25 In order to link up the "directional" oligodesoxynucleotides, the following "guide" oligodesoxynucleotides were used : - Gl= 5' TGTGTTTGAAGGGAATCGAAAGAGAGACACA 3' (SEQ.ID19) - G2= 5' GATTGGGTTTTTGTGTGGCTAAGATGTGTG 3' (SEQ.ID20) - G4= 5' TGTAGATGTGCCACAGAGTGGCATGCGT 3' (SEQ.ID22) 30 In order to carry out the LCR reaction, 10 pmol of the phosphorylated SI, S2, S5 and S7 "directional" oligodesoxynucleotides were ligated in the presence of 10 pmol of the "guide" oligodesoxynucleotides Gl, G2 and G4, 5 pl of Taq 10X DNA ligase buffer (New England Biolabs) and 40 units of Taq 35 DNA ligase (New England Biolabs). The ligation reaction was carried out in a GeneAmp PCR System 9700 thermocycle (Perkin 31 WO00/56906 PCT/IBOO/00317 Elmer, Norwalk, USA) and was comprised of one cycle for 1 min at 94oC, and then 8 identical cycles each comprising the following successive steps : 1 min at 650C, 1 min at 570C, 1 min at 520C, 1 min at 48 0 C, 1 min at 43 0 C, and finally 10 min at 37oC. Next, 5 the ligation reaction mixture was purified on a Qiaquick column according to the recommendations of the supplier. Finally, the PCR amplification of the obtained single DNA strand was carried out in a GeneAmp PCR System 9700 thermocycle in the presence of 100 pmol each of the oligodesoxynucleotide probes 10 5' CATGCTGCAGACTAGTGGATT 3', and 5' CGGGGATCCTCTAGGTTTCT 3', 50 nmol of each of the dNTP, 10 pl of Vent 10X DNA polymerase buffer (New England Biolabs), and 2 units of Vent DNA polymerase (New England Biolabs). The DNA was denatured for 5 min at 94oC, subjected to 25 cycles each comprising a 30 sec denaturing 15 step at 950C, of a 30 sec hybridization step at 56oC, and of 1 min of elongation at 720C, then continued elongation at 72oC for 5 min. The DNA fragments of the reaction mixture were digested with 20 units of BamHI for 45 min at 370C, then by 20 units of PstI for 20 1 h at 370C, and finally purified on a Qiaquick column. They were inserted into the plasmid pGEM3Z-petE /IV2, which had been previously digested by BamHI enzyme for 1 h at 370C and then by PstI enzyme for 1 h at 370C, subjected to 0.8% agarose gel electrophoresis, purified on a Quiaquick affinity column, !5 dephosphorylated for 1 h at 37°C in the presence of 12 pl of "Buffer 3" 10X (New England Biolabs) and of 5000 units of calf intestine alkaline phosphatase (CIP, New England Biolabs), and finally purified on a Quiaquick affinity column. To carry out the ligation, 25 ng of plasmid as treated above was contacted 0 with 100 ng of the DNA fragments obtained by PCR, in the presence of 1.2 pl of T4 10X DNA ligase buffer (New England Biolabs) and 400 units T4 DNA ligase (New England Biolabs) for 1 night at 180C. Previously prepared viable and competent Escherichia coli DH5a cells, were transformed with half of the 5 ligation reaction mixture. The DNA from the obtained clones, selected on LB media supplemented with ampicillin (50 mg/l), was 32 WO00/56906 PCT/IBOO/00317 extracted according to the alkaline lysis method and was analyzed by enzymatic digestion. Two resulting plasmids, pMRT1111 and pMRT1112, were sequenced. The plasmid pMRT1111 contains the expected promoter Mpr1lll (SEQ.ID08), whereas in 5 the plasmid pMRT1112, the promoter MPr1112 (Fig. IV) differs from MPrlll1 by a deletion of 35 bp containing the "G" box and stretching from position -127 to position -89 and also a deletion of two bp situated in positions -78 and -76 (SEQ.ID09). 3.4. Construction of the promoter MPr1153. 10 The promoter MPr1153 (Fig. IV) was obtained by fusing the sequence of 78 bp from the petE promoter stretching from position -582 to position -510 bp (SEQ.ID01) and bearing the "as-i like" and "nos enhancer like" elements into the promoter MPrl098 which was modified by the adjunction of the 18 bp 15 element containing the "G" box. To to this, the plasmid pMRT1111 was digested with 20 units of PstI enzyme and 1 unit of DraIll enzyme for 1 h at 37 0 C. The plasmid thus deleted of the 72 bp fragment containing the two "as-2" elements and the "as-l" element of CaMV, was isolated by 20 0.8% agarose gel electrophoresis, then purified on a Quiaquick affinity column. The 78 bp PstI/DraIII fragment containing the two "as-l like" and "nos enhancer like" elements of the petE promoter was generated by digesting 10 pg of the plasmid pMRT1108 with 20 units of PstI enzyme and 1 unit of DraIII 25 enzyme for 1 h at 370C, then the fragment was isolated by Nu-Sieve 3% agarose gel electrophoresis (EMC, Rockland, USA) and finally purified on a Quiaquick affinity column. The ligation was carried out with 20 ng of vector pMRT1111 PstI/DraIII and 80 ng of the 78 bp fragment for 1 night at 180C 30 in a reaction mixture of 10 pl in the presence of 1.0 pl of T4 10X DNA ligase buffer (New England Biolabs) and 400 units of T4 DNA ligase (New England Biolabs). Previously prepared viable and competent Escherichia coli DH5a cells were transformed with hald of the ligation reaction mixture. The plasmid DNA from the 35 obtained clones, selected on LB media supplemented with ampicillin (50 mg/l), was extracted according to the alkaline 33 WO00/56906 PCT/IBOO/00317 lysis method, and analyzed by enzymatic digestion. The plasmid obtained was designated pMRT1153 and the promoter sequence MPr1153 (SEQ.ID10) verified by sequencing. 3.5. Construction of the promoter Mpr1143. 5 The promoter MPr1143 (Fig. IV) was obtained by deleting the 72 bp sequence bearing the "as-2, as-2, as-l" elements of MPr111. This was achieved by digesting the plasmid pMRT1111 for 1 h at 37 0 C simultaneously with 20 units of PstI enzyme and 1 unit of DrallI enzyme. The plasmid thus deleted of the 70 bp fragment 10 containing the two as-2 elements and the as-1 element of CaMV were isolated by 0.8% agarose gel electrophoresis, then purified on a Quiaquick affinity column. The ends of this fragment were made blunt by the action of Pfu DNA polymerase (Stratagene, La Jolla, USA) according to the supplier's recommendations. This 15 fragment was religated for 1 night at 18 0 C in a 10 pl reaction mixture containing 20 ng of vector, 1.0 pl of the T4 10X DNA ligase buffer (New England Biolabs) and 400 units T4 DNA ligase (New England Biolabs). Previously prepared viable and competent Escherichia coli DH5a cells were transformed with half of the 20 ligation reaction mixture. The plasmid DNA of the obtained clones, selected on LB media supplemented with ampicillin (50 mg/l), was extracted according to the alkaline lysis method and analyzed by enzymatic digestion. The promoter sequence MPr1143 (SEQ. ID11) of one of these clones was verified by sequencing. 25 Example 4. Construction of binary plasmids containing the promoters MPr1151, MPr1149, MPr1170 and MPr1092. The preparation of the binary vector was the same for each of the expression cassettes containing MPr11ll, MPrl098, Mpr1143 30 and MPrl092. A 25 pg amount of the plasmid pGA492 (An, 1986) was digested with 80 units of HindIII enzyme for 1 h at 37 0 C, then purified on a Quiaquick affinity column. The protruding 5' ends of this plasmid were blunted using Pfu DNA polymerase (Stratagene, La Jolla, USA) according to the recommendations of 35 the supplier. The thus modified plasmid was digested with 80 units of EcoRI enzyme for 1 h at 37 0 C, then the resulting vector 34 WO00/56906 PCT/IB00/00317 deleted of a 291 bp fragment was separated on 0.7 % agarose gel and purified on a Quiaquick affinity column. 4.1. Production of pMRT1151. The expression cassette "MPr1111/uidA-IV2/nos term" was inserted 5 at the modified HindIII site of the binary plasmid pGA492. It was obtained from the plasmid pMRT1111, previously digested with 80 units of PstI enzyme for 1 h at 37oC and purified on a Quiaquick affinity column. The protruding 5' ends of this plasmid were blunted using Pfu DNA polymerase (Stratagene, La 10 Jolla, USA) according to the supplier's recommendations. The thus modified plasmid was digested with 80 units of EcoRI enzyme for 1 h at 37 0 C, then the 2.5 kb DNA fragment corresponding to the expression cassette was separated on 1 % agarose gel and purified on a Quiaquick affinity column. 15 The ligation was carried out by mixing 100 ng of binary plasmid pGA492 prepared as described above and 50 ng of expression cassette for 1 night at 18 0 C, in a 20 pl reaction volume in the presence of 2 pl of the T4 10X DNA ligase buffer (New England Biolabs) and 400 units T4 DNA ligase (New England Biolabs). 20 Previously prepared viable and competent Escherichia coli DH5a cells were transformed with half the ligation reaction mixture. The plasmid DNA of the obtained clones, selected on LB media supplemented with tetracycline (12 mg/l), was extracted according to the alkaline lysis method and analyzed by enzymatic 25 digestion as well as by gene amplification with the help of the oligodesoxynucleotides 5' ATATGAGACTCTAATTGGATACCGAGGGG 3', selected from the transfer DNA of the binary plasmid and 5' TTGATTTCACGGGTTGGG 3', selected from the expression cassette around the uidA sequence. The resulting clone was 30 designated pMRT1151. 4.2. Production of the binary plasmid pMRT1149. The expression cassette "MPr1143/uidA-IV2/nos term" was cloned at the modified HindIII site of the binary plasmid pGA492, following the same protocol as for plasmid pMRT1151, with the 35 exception that the expression cassette was isolated from the plasmid pMRT1143. The resulting clone was designated pMRT1149. 35 WO 00/56906 PCT/IB00/00317 4.3. Production of the binary plasmid pMRT1170. The expression cassette "petE promoter/uidA-IV2/nos term" was cloned at the modified HindIII site the binary plasmid pGA492 , following the same protocol as for plasmid pMRT1151, with the 5 exception that the expression cassette was isolated from the plasmid pGem3Z-petE/IV2 4.4. Production of the binary plasmid pGA492MPrl092. The promoter fragments MPrl092 and sequence "uidA-IV2/nos term" were inserted into the binary plasmid pGA492 prepared as 10 described above. The fragments were prepared in the following manner : The CaMV D35S promoter was isolated by digesting 10 pg of the plasmid pJIT163A with 40 units of KpnI enzyme for 1 h at 37 oC. The ends of this linear plasmid were blunted with the help of 6 15 units of T4 DNA polymerase (New England Biolabs) for 30 min at 37 0 C according to the manufacturer's recommendations. The thus modified plasmid was purified on a Quiaquick affinity column, then redigested with 80 units of HindIII enzyme for 1 h at 37 0 C. The 743 bp fragment corresponding to the promoter was separated 20 on 0.8 % agarose gel, then purified on a Quiaquick affinity column. The "uidA-IV2/nos term" sequence was obtained by digesting 4 Pg of the plasmid pMRT1092 with 40 units of HindIII enzyme and EcoRI enzyme for 1 h. The 2.2 kb fragment corresponding to the 25 sequence "uidA-IV2/nos term" was separated on 0.8 % agarose gel, then purified on a Quiaquick affinity column. The ligation between the three fragments was carried out by mixing 100 ng of binary plasmid, 50 ng of promoter fragment and 50 ng of the fragment corresponding to the sequence 30 "uidA-IV2/nos term" in a reaction volume of 20 pl, in the presence of 2 ipl of T4 10X DNA ligase buffer (New England Biolabs) and 400 units of T4 DNA ligase (New England Biolabs). The incubation was carried out in a thermocycle by subjecting the ligation mixture to 198 cycles each comprising a 30 sec 35 incubation at 30 0 C, and a 30 sec incubation at 100C. Previously prepared viable and competent Escherichia coli DH5x cells were 36 WO00/56906 PCT/IB00/00317 transformed with half the ligation reaction mixture. The plasmid DNA of the obtained clones, selected on LB media supplemented with tetracycline (12 mg/1), was extracted according to the alkaline lysis method and analyzed by enzymatic digestion and 5 gene amplification with the help of the oligodesoxynucleotides 5' ATATGAGACTCTAATTGGATACCGAGGGG 3', selected from the transfer DNA of the binary plasmid and 5' TTGATTTCACGGGTTGGG 3', selected from the expression cassette in the "uidA" sequence. One of the clones retained was designated pGA492MPrl092. 10 4.5 Production of the binary plasmid pMRT1182 The binary plasmid pMRT1182 was obtained by insertion of the promoter fragment CaMV D35S and of the sequence uidA-IV2/term-nos in the binary plasmid pMRT1118. This latter plasmid is described completely in French patent application 15 number FR 99 11112, filed on September 3, 1999, in the name of the present applicant, the specific description of which is incorporated herein by reference. The binary plasmid pMRT1118 (5971 pb) results from the introduction of a T-DNA fragment digested by AvrII enzyme into the AvrII site of another 20 dephosphorylated plasmid also fully described in the previously mentioned prior application to same applicant, and designated pMRT1106, also specifically incorporated herein by reference. In order to carry out the insertion, the pMRT1106 plasmid DNA (5 pg) was digested with AvrII enzyme, purified with the aid of the 25 < QIAquick PCR Purification >> kit, then dephosphorylated with 50 units of calf intestine alkaline phosphatase (New England Biolabs) in a final reaction mixture volume of 120 pl in the presence of 12 pl 3x 10 buffer (New England Biolabs) at 37 oC for 1 hour, isolated by electrophoresis on A 0.6% agarose gel in 30 TBE buffer, purified with a << QIAquick Gel Extraction >> kit, dephosphorylated a second time with the calf intestine alkaline phosphatase under the conditions mentioned above, and finally purified with a < QIAquick PCR Purification >> kit and transferred to 50 pl de H 2 0. 35 The PCR ligation reaction was carried out with 32,5 ng of digested dephosphorylated plasmid pMRT1106 and 50 ng of T-DNA 37 WO00/56906 PCT/IB00/00317 fragments digested in a reaction mixture volume of 10 pl in the presence of 1 pl T4 10x DNA ligase buffer (New England Biolabs) and 400 units of T4 DNA ligase (New England Biolabs). The ligation comprised 180 cycles each including 2 steps, the first 5 one at 100C for 30 seconds and the second step at 300C for 30 seconds in a < GeneAmp PCR System 9700 >> thermocycle. Previously prepared viable and competent Escherichia coli DH5a bacteria, were transformed (Hanahan, 1983). The plasmid DNA of the obtained clones, selected on LB media supplemented with 10 kanamycin (50 mg/l), was extracted according to the alkaline lysis method (Birnboim et Doly, 1979) and verified by enzymatic digestion and sequencing. The resulting plasmid was designated pMRT1118. The promoter CaMV D35S was isolated by digesting 10 pg of 15 plasmid pJIT163A successively with KpnI and HindIII enzymes for 1 hour at 370C. The 743 bp fragment corresponding to CaMV D35S was separated on 0.8% gel agarose, and then purified on a Qiaquick affinity column. The sequence "uidA-IV2/nos term" was obtained by digesting the plasmid pMRT1092 with 40 units of 20 HindIII and EcoRI enzymes for 1 hour. The 2.2 kb fragment corresponding to the required sequence was separated on 0.8% gel agarose, then purified on a Qiaquick affinity column. In parallel, 10 pg of binary plasmid pMRT1118 were digested successively with KpnI and EcoRI enzymes for 1 hour at 370C. The 25 linearized vector fragment was then dephosphorylated with 40 units of calf intestine alkaline phosphatase (New England Biolabs) in the presence of 3X buffer for 1 hour at 370C. The ligation was carried out in the presence of 100 ng of binary plasmid, 50 ng of the CaMV D35S fragment and 50 ng of the 30 fragment corresponding to "uidA-IV2/nos term" in a reaction volume of 20 pl, in the presence of T4 (lX) DNA ligase buffer and 400 units of T4 DNA ligase (New England Biolabs). Incubation was carried out by PCR cycles in a "GeneAmp PCR System 9700" thermocycle as described previously. Previously prepared viable 35 and competent Escherichia coli DH5x bacteria were transformed with half of the ligation reaction mixture. The plasmid DNA of 38 WO00/56906 PCT/IBOO/00317 the obtained clones, selected on LB media supplemented with kanamycin (50 mg/1), was extracted according to the alkaline lysis method and analysed by enzymatic digestion. The resulting plasmid was designated pMRT1182. 5 The plasmids pMRT1151, pMRT1149, pMRT1170 and pMRT1182 were transferred into the strain Agrobacterium tumefaciens LBA4404 according to the technique described by Holsters et al. (1978). The plasmid DNA of the obtained clones, selected on LB media supplemented with rifampicine (50 mg/1) and tetracycline (5 10 mg/1), was extracted according to the alkaline lysis method, and modified by adding lysozyme (25 mg/ml) to the cell resuspension buffer. The plasmid DNA obtained was analyzed by enzymatic digestion and by gene amplification with the help of the oligodesoxynucleotides 5' ATATGAGACTCTAATTGGATACCGAGGGG 3' 15 selected from the transfer DNA of the binary plasmid and 5' TTGATTTCACGGGTTGGG 3' selected from the expression cassette around the "uidA" sequence. The Agrobacterium clones obtained were used to carry out Agrobacterium mediated plant genetic transformation. 20 Example 5. Measure and comparison of the expression levels of the different promoters using transient expression techniques. 5.1 In vitro culture of tobacco, leaf preparation. The transient expression experiments were carried out on tobacco 25 leaves (Nicotiana tabacum L.) of the cultivar bpD6 aged 6 weeks. Mature seeds of tobacco cv. bpD6 were sterilised for 10 min in a saturated calcium hypochlorite solution (70 g/1), then rinced three times for 5 min in sterile deionized water. The sterile seeds were then placed on MS20 media (Murashige and Skoog, 1962) 30 and incubated for 6 weeks in a culture chamber (constant temperature of 240C, photoperiode 16 h obscurity / 8 h light, light intensity of 200 pmol photons.m-2.sec-1). In order to avoid splitting of the foliar mesophylll cells during transformation, the major leaves of the bpD6 tobacco 35 plants aged 6 weeks were excised from the plant 24 h before gene gun transformation, and placed, lignous face up, on light 39 WO00/56906 PCT/IBOO/00317 plasmolysis BY3 media (MS Salts 4,4 g/l, myoinositol 100 mg/l, thiamine 1 mg/l, KH 2
PO
4 200 mg/l, Saccharose 30 g/l, Sorbitol 45,5 g/l, 2,4 D 1 mg/l, pH 5,8). 5.2. Gold Particle Coating with DNA of the Chimeric 5 Constructions. Gene gun transformation requires prior coating of DNA onto gold bead spheres of 0,6 mm in diameter, that have been sterilized for 10 min absolute ethanol (99,98 %, at less than 0,02 % water), washed four times in sterile deionized water, and 10 finally preserved for a maximum of 4 weeks maximum at -20 0 C in a 50% glycerol solution. The concentration of all of the control and experimental plamsids used during transformation was adjusted to 1 mg/ml. In each transformation experiment, an internal reference control 15 (pCaMV35Sluc) was cotransformed in order to normalize the variations in GUS activity between the different experiments (Leckie and al., 1994). The coating of DNA onto the previously prepared gold beads was carried out in a sterile container under laminar flow 20 conditions. An aliquot of 1,8 mg of sterile beads in suspension in 30 pl of 50 % glycerol, was vigourously mixed in a vortexer for 1 min, then for 10 sec with 20 pl of DNA suspension containing 4 pg of one of the plamsids to be tested and 2 pg of the reference plasmid pCaMV35Sluc. Then, 20 pl of CaCl 2,5 M 25 were added and mixed vigourously for 10 sec. Next, 20 pl of spermidine 0,1 M were added to the mixture and whole mixture was agitated under vortex for 30 further seconds. The coating of DNA onto the beads was continued by incubating the mixture in ice for 15 min, then the coated beads were centrifuged at low 30 velocity for 5 sec and washed twice in absolute ethanol. After washing, the coated beads were resuspended in 32 pl of absolute ethanol, subjected to ultrasound three times each for 2 sec, vigourously mixed in the vortexer for 15 sec, then immediately split into 4 identical equal aliqouts on sterile 35 macrocarrier disks used in a Biolistic PDS-1000/He system prepared according to the manufacturer's recommendations 40 WO00/56906 PCT/IBOO/00317 (Bio-Rad, Hercule, USA). The whole arrangement of macrocarrier support and macrocarrier bearing the deposited beads was left to dry for 5 min. 5.3. Bombardment of foliar tissues of tobacco and transient 5 expression. The bombardment of tobacco leaves was carried out with the help of a Biolistic PDS-1000/He system following the general manufacturer's recommendations (Bio-Rad, Hercule, USA) with respect to handling and mounting of the different components of 10 the apparatus. Each leaf was bombarded twice succesively using the following conditions : - helium pressure used to accelerate the beads was equal to 6200 kPa (900 psi). - the plant sample was placed at a distance of 9 cm from the 15 bead acceleration zone. - the bombardment was carried out in a vacuum of 27 mm of mercury. After bombardment the leaves were left in BY3 medium and incubated for 48 h in the dark in a culture chamber at 240C. 20 This incubation enables transient expression of the trangenes introduced into the cells. 5.4. Evaluation of the activity of different promoters using histochemical staining. The revelation of the expression of -glucuronidase was carried 25 out by histochemical staining as described by Jeffersson et al. (1987). After 48 h in the culture chamber, each leaf was cut into two along the axis of the central spine. Half of the leaf was incubated in 8-glucuronidase staining buffer (5-bromo, 4-chloro, 3-indolyl glucuronide (X-Gluc) 500 mg/l, Triton x100 30 0.05% in 0.1 M, pH 7.0 phosphate buffer) for 48 h at 370C, whrereas the other half was frozen in liquid nitrogen, then conserved at -800C. After staining, the leaves were bleached by dipping them into two 95 % ethanol baths for respectively 3 and 12 h, then rinsed 35 in distilled water and dried flat between two sheets of cellophane. 41 WO00/56906 PCT/IBOO/00317 The promoter activity of the different constructs was evaluated by the number of blue spots revealed on each leaf after two bombardments amounting to 2 pg of DNA bearing the GUS reporter gene. 5 Three categories of promoters were identified. The leaves bombarded with the promoters MPrl096, MPr1098, MPr1108, MPrl109, MPr1143 and MPr1153 all showed an average of less than 30 blue spots. The leaves bombarded with the promoters petE, MPr1097 and MPr1110 all showed a number of blue spots between 50 10 and 150. Finally , the leaves bombarded with MPr1111 and the reference promoter MPrl092 had a very large number of blue spots on average and in general greater than 200. In conclusion, the chimeric promoters MPr11l0 and MPrl11 enable expression of permettent d'obtenir une expression of 15 8-glucuronidase at a level greater than or equal to that of the whole petE promoter ; and MPrlll shows promoter activity at least as comparable as that obtained by the strong constitutive reference promoter D35S prom. 5.5. Quantification of the expression of B-glucuronidase by the 20 different promoters using luminometric enzyme assay. The frozen leaf halves were ground in a mortar, and the powder was left to defrost in the extraction buffer at 1 ml of buffer for 200 mg of plant tissue (Tris Phosphate 25 mM pH 7.8, Dithiothreitol 2 mM, 1,2-diaminocyclohexane 25 N,N,N',N'-tetracetic acid 2 mM, glycerol 10 %, Triton x100 1 %). The mixture was homogenized then incubated for 15 min in ice before being clarified by centrifugation for 5 min at 16060 g. The GUS activity was measured on 20 pl crude clarified leaf 30 extract with the help of the detection kit "GUS-Light chemiluminescent reporter gene assay" (Tropix Inc., Bedford, USA) according to the supplier's recommendations. The measurement of light emission was carried out with the help of a Lumat LB 9507 luminometer (EGG-Berthold, Bad Wildbad, 35 Allemagne). Luciferase activity was measured on 20 pl crude leaf extract 42 WO00/56906 PCT/IB00/00317 with the help of the detection kit "Luciferase assay system" (Promega Corp., Madison, USA) according to the supplier's recommendations. Light emission measurement was effected with the help of a Lumat LB 9507 luminometer. 5 The results are reported in Fig. V. For each experiment (one bombarded leaf = one crude extract), the ratio between the measured 8-glucuronidase activity and luciferase activity as measure by the luminometer, was calculated. The average of the different experiments for a given construct and mean standard 10 error were determined. The promoters can be divided into 6 classes ordered on an increasing scale of expression starting from the weakest (class 1) to the strongest (class 6) : - Class 1 inclues the promoters MPrl108 and MPrll09 (Fig. IV). 15 The expression conferred by these promoters seems to differ very little from that obtained with the construction pMRT1144 (Fig. I), which contains no promoter. The fusion of the "as-l like" and "nosE like" boxes to the minimal promoter MPrl098 (Fig. IV) to obtain MPr1108, only slightly lowers the average expression 20 promoted by MPrl098. This result seems to suggest that a very slight inhibitor effect is due to these boxes and their position within MPr1108. The promoter MPrl109 confers an essentially identical expression to that obtained with promoter MPrll08. The deletion of the sequence siutated downstream of the 25 transcription initiation site, that is to say the 5' untranslated region, does not appear to modify the expression obtained with MPr1108. - Class 2 comprises promoters MPrl098, MPr1143 and MPr1112 (Fig. IV). The promoters MPrl098 and MPr1143 show similar activity. 30 The promoter Mpr1143 results from the insertion of a "G" box at a distance of 36 bp upstream of the "CAAT" box in the minimal promoter MPrl098. The presence of this box does not appear to have a significant effect on the expression obtained with the promoter MPrl098. The promoter MPr1112 includes upstream of the 35 "CAAT" box, a duplication of the "as-2" box followed by the "as-l" box originating from the promoter 35S of CaMV. These 43 WO00/56906 PCT/IBOO/00317 elements on their own do not appear to contribute to improving the epxression rate which is essentially identical to that obtained with the promoter MPrl098. - Class 3 includes promoters MPrl096 and MPrl097 (Fig. IV). The 5 expression conferred by these two promoters is identical. The creation of MPrl096 by deletion of the fragments SphI-SpeI bearing the "nosE like" box and Spel-Spel of MPrl097, bearing a region from the sequence enhancer of the petE promoter (Fig. IV), does not appear to affect the expression rate. In promoter 10 MPrl096, the presence of the "G" box, preceded by the 31 bp of the petE sequence enhancer and at a distance of 122 bp from the "CAAT" box appears to enable the increase in the expression rate obtained by MPrl098 by a factor of 2.5. It should be noted that in the case of MPr1143, the presence of the "G" box preceded by 15 the 28 bp petE sequence enhancer at a distance of 36 bp from the "CAAT" box does not permit an increase in the rate of expression obtained with MPrl098. It would thus seem that the distance between the "G" and "CAAT" boxes influences the rate of expression. 20 - Class 4 includes promoter petE (Fig. IV) which is used as a reference. - Class 5 comprises the promoter MPrlllO0 (Fig. IV). The fusion of the as-2 and as-1 boxes upstream of the promoter MPr1143 creating the promoter MPrlllO0 enables a considerable increase in 25 the expression rate that is very much higher than that obtained with the petE promoter (by a factor of 1.4). It appears that the "G", "as-l" and "as-2" boxes together have an active positive synergic effect with respect to the expression. - Class 6 covers promoters MPrllll (Fig. IV) and MPrl092 (Fig. 30 I). The promoter MPrlll confers an expression rate similar to that of the reference double 35S CaMV promoter (MPrl092). The addition of an "as-2" element or box considerably increases the expression rate with respect to that obtained by MPrlllO0 (by a factor of 1.7). These elements appear to act synergistically. 35 The duplication of the "as-2" box also increases this effect. In conclusion, the chimeric promoter MPrlllO0 enables an average 44 WO00/56906 PCT/IB00/00317 expression of 8-glucuronidase at a level greater than or equal to the whole petE promoter. The promoter MPr1lll has a promoter activity comparable to the average activity obtained with the reference promoter D35S. 5 These results are in agreement with those observed after histochemical staining of the bombarded leaves with the same promoters. The CaMV D35S promoter is commonly reported in the literature as being a strong promoter. The chimeric promoters of the present 10 invention bring an increase in the promoter activity of the GUS reporter gene of the order of 8 to 12 times that of the reference promoter CaMV 35S (Kay and al., 1987).Furthermore, MPr1lIl constitutes one of the most active and strongest chimeric promoters in tobacco leaves described to date. 15 The promoters of lesser strength can be used as promoters associated with genes coding for selection agents, for example, in order to confer antibiotic resistance, for example in the same way as promoters of the "nos" type. Example 6. 20 Expression of the different promoters in tobacco after stable transformation. 6.1. Stable transformation in tobacco. The transformation of tobacco (Nicotiana tabacum L., cultivar bpD6) was carried out by infecting foliar disks isolated from 25 tobacoo plants aged 6 weeks by recombinant Agrobacterium according to the method described by Horsch et al. (1985). During transformation, the Petri dishes were incubated in a culture chamber under the following conditions : temperature of 24oC, photoperiod of 8 h darkness / 16 h light, luminous 30 intensity of 200 pmol photons.m-2.sec-1 , and apart from the initial coculture step, all of the callogenesis, regeneration, and rooting steps were carried out on varying selective media supplemented with Augmentin ® (400 mg/l) and Kanamycin ® (200 or 100 mg/l) ; 35 The different steps and the media were the following : - a coculture step lasting three, during which the Agrobacteria 45 WO00/56906 PCT/IBOO/00317 infect the plant cells, on a solid MS30 coculture media (media based on MS (Murashige and Skoog, 1962) supplemented with vitamins (Gamborg and al., 1968) 4.4 g/l (Sigma, M0404), Saccharose 30 g/l, agar 8 g/l (Merck), pH 5.7), Benzyl Amino 5 Purine at 1 mg/l and Indole-3 acetic acid at 0,1 mg/l . - a bud tip formation step consisting of four weeks in a culture chamber on a solid MS20 regeneration media (Salts and vitamins MS 4,4 g/l (Sigma, M0404), Saccharose 20 g/l, , agar 8 g/l (Merck), pH 5.7), supplemented with Benzyl Amino Purine at 1 10 mg/l, Indole-3 Acetic acid at 0.1 mg/l, Augmentin ® at 400 mg/l and Kanamycine * at 200 mg/l. - a development and rooting step lasting three weeks in a culture chamber on MS20 solid development media supplemented with Augmentin * at 400 mg/l and Kanamycine at 100 mg/l. 15 - a repotting step into glass pots in a culture chamber on sur MS20 solid development media supplemented with Augmentin ® at 400 mg/1 and Kanamycine ® at 100 mg/l. 6.2. Comparison of chimeric promoter activity after stable expression in tobacco plants. 20 P-glucuronidase activity was measured in primary transformants 2, 4, 6, 8 and 10 weeks after their transfer to greenhouse. For each plant, 3 samples were taken and pooled together in a test tube. One sample was taken from an "old" leaf (basal foliar level), one from a mature leaf (of a median leaf level), and one 25 on a young leaf located at the apex of the plant. Each sample was ground with liquid nitrogen in a mortar and the powder was resuspended in extraction buffer (Tris phosphate 25 mM, pH=7.8, dithiothreitol 2 mM, 1,2-diaminocyclohexan, N, N, N',N'-tetracetic acid 2 mM, glycerol 10 %, Triton X100 1 %) at a 30 ratio of 1 ml buffer per 200 mg plant powder. The material was homogenized, incubated for 15 min on ice before being clarified by centrifugation at 16060 g for 5 min. GUS activity was measured on 20 ml of clarified crude extract with the help of the "GUS-Light chemiluminescent reporter gene 35 assay" detection kit (Tropix Inc., Bedford, USA) according to the manufacturer's recommendations. Measurements of light 46 WO00/56906 PCT/IBOO/00317 emission were carried out using the Lumat LB 9507 luminometer (EGG-Berthold, Bad Wildbad, Germany). Total protein content in crude extract was assessed by the Bradford's technique (Bradford, 1976), using the "Bio-Rad 5 protein assay" reagent (Bio-Rad, Manchen, Allemagne) according to the manufacturer's recommendations. Reporter gene activity in the different categories of plants was analyzed over the population of 20 transformants per construct, and over the whole period of plant growth and development. 10 Analysis was not performed at the individual level because of random insertion sites and variable copy number in the different transformants of a given category. The results for the chimeric promoter MPrllll, compared to the original pPetE promoter, the minimal MPr1143 and the reference 15 MPrl092 promoter are presented Fig.VI. GUS activity in MPrl092 reference plants showed relatively little variation compared to what was observed in plants transformed with plastocyanin-based promoters. Activity decreased slightly between 2 and 4 weeks after transfer of the 20 plants to greenhouse; increased about 4 times at 6 weeks, dropped again at 8 weeks to values observed at 4 weeks and finally increased slightly at 10 weeks. Analysis of plastocyanin-based promoters revealed that whatever promoter or plant considered, GUS activity increased regularly from 2 to 6 25 weeks after transfer to greenhouse and decreased thereafter till flowering. This evolution of GUS activity was correlated to plant developement, since the plastocyanin gene is actively expressed in photosynthetic tissues. Activities of pPetE and derived 30 promoter therefore followed active growth of the plants spanning from greenhouse transfer to 6-8 weeks after acclimation, followed by a slower development of the plants from 8 weeks to flowering that occured 10-12 weeks after transfer to greenhouse. In comparison, the reference MPr1092 promoter, known as a highly 35 active constitutive promoter was less dependent on these developmental associated effects. 47 WO00/56906 PCT/IB00/00317 Comparison of transformants bearing the chimeric promoter MPr1143 and the reference MPr1092 showed that whatever stage of development, "MPr1143 plants" exhibited a very low GUS activity compared to "D35S plants". These data revealed that MPr1143 was 5 only able to drive minimal expression of the reporter gene at a basal level and confirmed the results obtained after transient expression experiments showing that the "G box" by itself, inserted into the minimal pPetE sequence was not sufficient to promote expression effectively. 10 Comparison of the population of transformants bearing the original pPetE promoter to the reference "MPrl092 plants" showed that pPetE was as active as the reference at 2 weeks after transfer of the plants to greenhouse, 3 to 4 times more active during active development (from 2 to 8 weeks). The differences 15 between the two promoters decreased regularly from 6 weeks after transfer and was reversed at 10 weeks since reference plants exhibited an average activity greater than twice that of "pPetE plants". These data did not corroborate those obtained after transient expression, in which pPetE was 2,5 times less active 20 than MPr1092. Comparison between "MPrl1l1 plants" and those bearing pPetE revealed that MPr1111 was on average 2 to 3 times less active than pPetE till 6 weeks and was at least as active thereafter. At 8 and 10 weeks a few "MPrll11 individuals" were indeed more 25 active than "PetE ones". To this extent, stable expression led to a different conclusion compared to transient expression in which MPr1111 was on average 2,5 more active than pPetE. MPr1111 was shown to be more active than the reference MPrl092 in the population of primary transformants over a period of 30 growth and development extending form 4 to 8 weeks after transfer of plants to greenhouse, with a maximum of 2 to 3 times more activity at 8 weeks. On the basis of these time course analyses we can conclude that respective strength of the promoters is not static throughout 35 growth of the plants, and this is probably due to different regulation processes. MPrl11 is the promoter that drove 48 WO00/56906 PCT/IB00/00317 expression of the reporter protein GUS at the highest level 8 weeks after transfer of the plants to greenhouse, and therefore appears to be the best candidate to be used for expression of large quantities of heterologous proteins at this stage of 5 tobacco development. 49 WO00/56906 PCT/IB00/00317 Bibliographic references 5 An G. (1986). Development of plant promoter expression vector and their use for analysis of differential activity of nopaline synthase promoter in transformed tobacco cells. Plant Physiol. 81, 86-91. Barany F. (1991). The ligase chain reaction in a PCR world. PCR 10 Methods Appl. 1, 5-16. Birnboim H. C. and Doly J. (1979). A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nuc. Ac. Res. 7, 1513. Bradford M. (1976). A rapid and sensitive method for the 15 detection of microgram quantities of proteins utilising the principle of protein-dye binding. Anal. Biochem. 72, 248-254. Fromm M.E., Taylor L.P. and Walbot V. (1986). Stable transformation of maize after gene transfer by electroporation. Nature, 319, 791-793. 20 Gamborg O.L., Miller R.A. and Ojima K. (1968). Nutrient requirements of suspension cultures of soybean root cells. Exp. Cell Res. 50, 151-158. Gaubier P., Raynal M., Hull G., Huestis G.M., Grellet F., Arenas C., Pages M. and Delseny M. (1993). Two different Em-like 25 genes are expressed in Arabidopsis thaliana seeds during germination. Mol. Gen. Genet. 238, 409-418. Gufrineau and Mullineaux (1993). In Plant molecular biology labfax, Croy R.R.D. (Ed.), BioS Scientific Publishers, Blackwell Scientific Publications. 30 Jefferson R.A., Burgess S.M. and Hirsh D (1986). 8-glucuronidase as a gene-fusion marker. Proc. Nat. Acad. Sci. USA, 83, 8447-8451. Jefferson R.A., Kavanagh T.A. and Bevan M.W. (1987). GUS fusions : B-glucuronidase as a sensitive and versatile gene fusion 35 marker in higher plants. EMBO J. 6, 3901-3907. Hanahan D. (1983). Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166, 557. 50 WO00/56906 PCT/IB00/00317 Holsters M., Dewaele D., Depicker A., Messenf E., Van Montagu M. and Schell J. (1978). Transfection and transformation of Agrobacterium tumefaciens. Mol. Gen. Genet. 136, 181-187. Horsch R.B., Fry J.E., Hoffmann N.L., Eiholtz D., Rogers S.G. 5 and Fraley R.T. (1985). A simple and general method for transferring genes into plants. Science 227, 129-1231. Kay R., Chan A., Daly M. and McPherson J. (1987). Duplication of CaMV 35S promoter sequences creates a strong enhancer for plant genes. Science 236, 1299-1302. 10 Lam E., Benfey P. N., Gilmartin P. M., Fang R. X. and Chua N. H. (1989). Site-specific mutations alter in vitro factor binding and change promoter expression pattern in transgenic plants. Proc. Natl. Acad. Sci. USA, 86, 7890-7894. Lam E. and Chua N. H. (1989). ASF-2 : a factor that binds to 15 the cauliflower mosaic virus 35S promoter and a conserved GATA motif in Cab promoters. Plant Cell, 1, 1147-1156. Last D. I. and Gray J. C. (1989). Plastocyanin is encoded by a single-copy gene in the pea haploid genome. Plant Mol. Biol. 12, 655-666. 20 Leckie L., Devoto A. and of Lorenzo G. (1994). Normalisation of GUS by LUC activity from the same cell extract reduces transformation variability. Biotechniques 17, 52-56. Murashige T. and Skoog F. (1962). A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiol. 25 Plant. 15, 473-497. Pwee K.H. and Gray J.C. (1993). The pea plastocyanin promoter directs cell-specific but not full light-regulated expression in transgenic tobacco plants. Plant J. 3, 437-449. Sanger F., Nicklen S. and Coulson A. R. (1977). DNA sequencing 30 with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74, 5463-5467. Torrent M., Alvarez I., Geli M.I., Dalcol I. and Ludevid D. (1997). Lysine-rich modified g-zein accumulate in protein bodies of transiently transformed maize endosperms. Plant Mol. Biol. 35 34, 139-149. Vancanneyt G., Schmidt R., O'Connor-Sanchez A., Willmitzer L. 51 WO 00/56906 PCT/IB00/00317 and Rocha-Sosa M. (1990). Construction of an intron-containing marker gene : Splicing of the intron in transgenic plants and its use in monitoring early events in Agrobacterium-mediated plant transformation. Mol. Gen. Genet. 220, 245-250. 5 52

Claims (1)

  1. [CLAIMS]
    1) Chimeric expression promoter comprising at least one nucleic acid sequence derived from a promoter of the pea plastocyanin gene having the sequence identified under the number SEQ.IDOl.
    2) Chimeric promoter according to claim 1, wherein the nucleic acid sequence derived from the promoter of the pea plastocyanin gene is selected from the group consisting of the sequences identified under the numbers SEQ.ID02, SEQ.ID03, SEQ.ID04, SEQ.ID05, SEQ.ID06, SEQ.ID07, SEQ.ID08, SEQ.ID09, SEQ.ID10, and SEQ.ID11.
    3) Chimeric expression promoter comprising a "G" box operably or functionally linked upstream of at least one "CAAT" box, "TATA" box and transcription initiation site (+1). 4) Chimeric expression promoter according to claim 3, wherein the "G" box is situated between positions - 225 and - 65 with respect to the transcription initiation site (+1).
    5) Chimeric expression promoter according to claim 3, wherein the "G" box is situated between positions - 201 and - 115 with respect to the transcription initiation site (+1).
    6) Chimeric expression promoter according to claim 3, wherein the "G" box is situated at position - 201 with respect to the transcription initiation site (+1).
    7) Chimeric expression promoter according to claim 3, wherein the "G" box is situated at position - 115 with respect to the transcription initiation site (+1).
    8) Chimeric promoter according to claim 3, wherein the "G" box is of plant origin.
    9) Chimeric promoter according to claim 3, wherein the "G" box is obtained from a promoter of the pea plastocyanin gene .
    10) Chimeric promoter according to claim 3, wherein the "G" box is obtained from the petE promoter of the pea plastocyanin gene . 11) Chimeric promoter according to any one of claims 3 to 10, wherein it further comprises a "nos E like" box operably or functionally linked upstream of the "G" box.
    12) Chimeric promoter according to any one of preceding claims 3 to 11, wherein it further comprises at least one "asl" or "asl like" box operably or functionally linked to the "G" box.
    13) Chimeric promoter according to claim 12, wherein the promoter comprises two or more "asl" or "asl like" boxes, arranged either contiguously or separately
    14) Chimeric promoter according to claim 12 or claim 13, wherein the promoter comprises four "asl" or "asl like" boxes.
    15) Chimeric promoter according to any one of preceding claims 12 to 14, wherein the "asl" or "asl like" boxes are linked both upstream and downstream of said "G" box., and preferably are linked upstream thereof. 16) Chimeric promoter according to any one of preceding claims 12 to 15, wherein one or more of the the "asl" or "asl like" boxes is arranged in inverse order, and preferably in inverse repeat order.
    17) Chimeric promoter according to any one of the preceding claims 3 to 16, wherein it further comprises at least one "as2" box operably linked to the "G" box.
    18) Chimeric promoter according to any one of the preceding claims wherein the promoter comprises at least two or more "as2" boxes, and preferably four "as2" boxes. 19) Chimeric promoter according to claim 18, wherein said "as2" boxes are linked both upstream and downstream of said "G" box, and preferably are linked upstream thereof.
    20) Chimeric promoter according to any one of preceding claims 17 to 19, wherein one or more of the the "asl" or "asl like" boxes is arranged in inverse order, and preferably in inverse repeat order.
    21) Chimeric promoter according to any one of the preceding claims 3 to 20, wherein it comprises at least one nucleic acid sequence selected from the group consisting of the sequences identified under the numbers SEQ.ID02, SEQ.ID03, SEQ.ID04, SEQ.ID05, SEQ.ID06, SEQ.ID07, SEQ.ID08, SEQ.ID09, SEQ . I DI O , SEQ . ID11 .
    22) Expression cassette comprising at least one nucleic acid sequence derived from a promoter of the pea plastocyanin gene, operably or functionally linked to a nucleic acid sequence to be expressed coding for a polypeptide to be produced, itself operably or functionally linked to a transcription termination nucleic acid sequence, wherein the nucleic acid sequence derived from a promoter of the pea plastocyanin gene is selected from the group consisting of the sequences identified under the numbers SEQ.ID02, SEQ.ID03, SEQ.ID04, SEQ.ID05, SEQ.ID06, SEQ.ID07, SEQ.ID08, SEQ.ID09, SEQ.IDIO, and SEQ.ID11.
    23) Isolated promoter nucleic acid sequence, wherein the sequence is selected from the group consisting of the sequences identified under the numbers SEQ.ID02, SEQ.ID03, SEQ.ID04, SEQ.ID05, SEQ.ID06, SEQ.ID07, SEQ.ID06, SEQ.ID09, SEQ.IDIO, and SEQ.ID11.
    24) Directional desoxynucleotide building block for a chimeric expression promoter or an isolated promoter nucleic acid sequence according to any one of claims 1 to 21 or 23, wherein the sequence is selected from the group consisting of the sequences identified under the numbers SEQ.ID12, SEQ.ID13, SEQ.ID14, SEQ.ID15, SEQ.ID16, SEQ.ID17 and SEQ.IDlδ.
    25) Guide desoxynucleotide building block for a chimeric expression promoter or an isolated promoter nucleic acid sequence according to any one of claims 1 to 21, or 23, wherein the sequence is selected from the group consisting of the sequences identified under the numbers SEQ.ID19, SEQ.ID20, SEQ.ID21 and SEQ.ID22.
    26) Vector comprising a promoter, or a promoter nucleic acid sequence, capable of initiating transcription of nucleic acid sequence coding for a polypeptide to be produced, wherein the promoter or the promoter nucleic acid sequence correspond to a chimeric expression promoter or a promoter nucleic acid sequence according to any one of claims 1 to 21, or 23. 27) Vector according to claim 26, wherein the vector is chosen from the group consisting of the binary vectors idenditified under the numbers pMRT1151, pMRT1149, pMRTll70.
    28) Method for the manufacture of a chimeric expression promoter or an isolated promoter nucleic acid sequence according to any one of claims 1 to 21 or 23, wherein it comprises the steps consisting of :
    - carrying out a ligation chain reaction, called LCR, that produces a continuous single stranded DNA from at least one directional desoxynucleotide building block selected from the group consisting of the "directional" desoxynucleotides SI, S2, S3, S4, S5, S6, and S7 identified under the numbers SEQ.ID12, SEQ.ID13, SEQ.ID14, SEQ.ID15, SEQ.ID16, SEQ.ID17 and SEQ.IDlδ respectively, and at least one "guide" desoxynucleotide building block, for said promoter nucleic acid sequence or promoter, selected from the group consisting of the "guide" desoxynucleotides Gl, G2, G3, and G4 identified under the numbers SEQ.ID19, SEQ.ID20, SEQ.ID21 and SEQ.ID22 respectively ;
    - carrying out PCR amplification on the single stranded DNA obtained in the previous step enabling the production of a double stranded DNA corresponding to the chimeric expression promoter or the promoter nucleic acid ;
    - optionally isolating the promoter or the promoter nucleic acid sequence.
    29) Method according to claim 28, wherein the desoxynucleotide blocks are phosphorylated before ligation. 30) Method according to claim 28, wherein the ligation is carried out in the presence of at least one DNA ligase in a thermocycle, under the following conditions :
    - one cycle of about one minute at about 94 °C ;
    - eight identical cycles each of which consists of the following steps :
    - one minute at 65°C, one minute at 57°C, one minute at 52°C, one minute at 48°C, one minute at 43°C and ten minutes at 37°C.
    31) Transgenic plant having stably integrated into its genome at least one promoter or at least one promoter nucleic acid sequence according to any one of claims 1 to 21, or 23 respectively.
    32) Transgenic plant according to claim 31, wherein the plant is selected from dicotyledonous species, preferably potato, tobacco, cotton, lettuce, tomato, melon, cucumber, pea, rape, beetroot, or sunflower, or monocotyledonous species, preferably wheat, barley, oat, rice, or corn.
    33) Propagule of a transgenic plant according to any one of claims 31 or 32.
    34) Propagule of a trangenic plant according to claim 33, wherein the propagule is a seed.
    35) Cell containing a promoter or a promoter nucleic acid sequence according to any one of claims 1 to 21, or 23 respectively.
    36) Cell according to claim 35, wherein the cell is selected from plant cells, human cells, animal cells, insect cells, bacterial cells, algal cells, and fungal cells, and preferably is a plant cell.
    37) Method for expressing a nucleic acid sequence, or gene, coding for a polypeptide to be produced, in a cell, wherein said method comprises the steps consisting of :
    - transforming the cell with a vector comprising at least one promoter or at least one promoter nucleic acid according to any one of claims 1 to 21, or 23 operably linked to a nucleic acid sequence, or gene, coding for a polypeptide to be produced, itself operably linked to a transcription terminator signal ;
    - culturing the transformed cell under conditions enabling the expression of the nucleic acid sequence, or gene, coding for the polypeptide, whereby the polypeptide is produced. 38) Method according to claim 37, wherein the cell is prokaryote or eukaryote cell.
    39) Method according to any one of claims 37 or 38, wherein the cell is one chosen from the group consisting of microbial cells, fungal cells, insect cells, animal cells, and plant cells.
    40) Method according to any one of claims 37 to 39, wherein the cell is a plant cell.
    41) Method for the manufacture of a transgenic plant according to any one of claims 31 or 32, or of a propagule according to claim 33, wherein the method comprises the steps consisting of :
    - transforming a plant cell with a vector comprising at least one promoter or at least one promoter nucleic acid sequence according to any one of claims 1 to 21, or 23 ;
    - selecting the plant cell having integrated the promoter or the promoter nucleic acid sequence ;
    - propagating the transformed and selected plant cell, either through culture, or through regeneration of whole chimeric or transgenic plants.
AU31853/00A 1999-03-22 2000-03-20 Chimeric promoters based on the plastocyanin pete promoter from pea Ceased AU767285B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9903635A FR2791358B1 (en) 1999-03-22 1999-03-22 CHEMICAL EXPRESSION PROMOTERS, EXPRESSION CASSETTES, PLASMIDS, VECTORS, PLANTS AND TRANSGENIC SEEDS CONTAINING THEM AND METHODS OF OBTAINING THEM
FR9903635 1999-03-22
PCT/IB2000/000317 WO2000056906A1 (en) 1999-03-22 2000-03-20 Chimeric promoters based on the plastocyanin pete promoter from pea

Publications (2)

Publication Number Publication Date
AU3185300A true AU3185300A (en) 2000-10-09
AU767285B2 AU767285B2 (en) 2003-11-06

Family

ID=9543560

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31853/00A Ceased AU767285B2 (en) 1999-03-22 2000-03-20 Chimeric promoters based on the plastocyanin pete promoter from pea

Country Status (7)

Country Link
EP (1) EP1163351A1 (en)
JP (1) JP2002539795A (en)
CN (1) CN1351669A (en)
AU (1) AU767285B2 (en)
CA (1) CA2366228A1 (en)
FR (1) FR2791358B1 (en)
WO (1) WO2000056906A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
CA2385348C (en) * 1999-10-04 2008-12-02 Medicago Inc. Promoter for regulating expression of foreign genes
WO2001053476A2 (en) * 2000-01-21 2001-07-26 Pioneer Hi-Bred International, Inc. Novel plant promoters and methods of use
NZ536037A (en) 2002-03-20 2008-04-30 Simplot Co J R Refined plant transformation
ATE490330T1 (en) 2005-07-27 2010-12-15 Simplot Co J R MARKER-FREE PLANT TRANSFORMATION
CN101466829B (en) 2006-02-09 2012-03-14 麦迪卡格公司 Synthesis of sialic acid in plants
CN101778943A (en) * 2007-06-15 2010-07-14 麦迪卡格公司 Protein production in plants
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
US20100275326A1 (en) * 2007-10-08 2010-10-28 Santanu Dasgupta Engineered dicotyledonous promoters capable of expressing in monocotyledonous plants
JP2011509661A (en) 2007-11-27 2011-03-31 メディカゴ インコーポレイテッド Recombinant influenza virus-like particles (VLP) produced in transgenic plants expressing hemagglutinin
WO2010003235A1 (en) 2008-07-08 2010-01-14 Medicago Inc. Soluble recombinant influenza antigens
ES2669303T3 (en) 2009-06-24 2018-05-24 Medicago Inc. Chimeric pseudoviral influenza particles comprising hemagglutinin
CN102549008A (en) 2009-09-22 2012-07-04 麦迪卡格公司 Method of preparing plant-derived proteins
TWI620816B (en) 2011-03-23 2018-04-11 苜蓿股份有限公司 Method of recovering plant-derived proteins
US9670497B2 (en) * 2014-05-19 2017-06-06 Azargen Biotechnologies (Pty) Ltd. Synthetic promoter construct for transgene expression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9524350D0 (en) * 1995-11-29 1996-01-31 Lynxvale Ltd Enhancer-increased gene expression in plants

Also Published As

Publication number Publication date
AU767285B2 (en) 2003-11-06
CN1351669A (en) 2002-05-29
EP1163351A1 (en) 2001-12-19
JP2002539795A (en) 2002-11-26
FR2791358A1 (en) 2000-09-29
WO2000056906A1 (en) 2000-09-28
FR2791358B1 (en) 2003-05-16
CA2366228A1 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
AU767285B2 (en) Chimeric promoters based on the plastocyanin pete promoter from pea
CA1309365C (en) Ocs enhancer
AU782218B2 (en) Flax seed specific promoters
EP0521915A1 (en) Plant promoter
FI110323B (en) A recombinant construct to increase gene expression in plants
EP1165815B1 (en) Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus
AU6717700A (en) Clean synthetic vectors, plasmids, transgenic plants and plant parts containing them, and methods for obtaining them
US5362864A (en) Trans-activating factor-1
EP1220935B1 (en) Synthetic and chimeric promoters, expression cassettes, plasmids, vectors, transgenic plants and seeds containing them, and method for producing them
US20040088760A1 (en) Gossypium hirsutum tissue-specific promoters and their use
US20040073022A1 (en) Cryptic regulatory elements obtained from plants
WO1999067389A2 (en) Cryptic regulatory elements obtained from plants
RU2697014C2 (en) Method for efficient biosynthesis of recombinant proteins in dicot plants using promoter of pro-smamp1 gene from stellaria media
Wang et al. A novel bi-directional promoter cloned from melon and its activity in cucumber and tobacco
US20060236435A1 (en) Chimeric plant promoters and plants containing the same
WO2006076808A1 (en) Transcriptional termination of transgene expression using host genomic terminators
JPH06189777A (en) Expression plasmid for seed
JP2005168471A (en) Promotor having green-colored tissue specific expression activity
EP1088073A2 (en) Cryptic regulatory elements obtained from plants
MXPA02004307A (en) Seed preferred promoter from barley.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)